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923-145 Is the Non-inferiority Claim for Bivalirudin in 
Percutaneous Coronary Intervention Warranted? 
REPLACE-2 Revisited
Sanjay Kaul, George A. Diamond, Cedars-Sinai Medical Center, Los Angeles, CA
Background:An active control non-inferiority (NI) trial, REPLACE-2, concluded that 
bivalirudin (Bv) is not inferior to heparin plus glycoprotein 2b/3a inhibitor (hep+GPI) in 
preventing ischemic complications during PCI.
Objective: To perform NI analysis on efﬁcacy (death, MI & urgent target vessel 
revascularization) outcome alone (triple endpoint), and compare with combined efﬁcacy 
and safety (bleeding) assessment (quadruple endpoint).
Methods: Marginal approach determined if Bv is inferior to hep+GPI by no more than a 
pre-deﬁned margin (M) derived from a random effects meta-analysis of EPISTENT and 
ESPRIT (odds ratio margin was 1.11 for quadruple and 1.21 for triple endpoint). NI is 
inferred if 95% upper limit of CI <M. Fractional approach determined if Bv preserved at 
least 0.5 fraction (F) of hep+GPI effect. NI is established if 95% lower limit of F >0.50.
Results:NI is established with marginal and fractional analysis for quadruple endpoint. 
In contrast, NI is not established for triple endpoint with marginal and barely established 
with fractional approach. The combined outcome was driven in favor of Bv by a greater 
difference in safety (43% odds reduction) compared to efﬁcacy (9% odds increase).
Conclusions: Despite published conclusions to the contrary we conclude that Bv has not 
been shown to be noninferior to planned hep+GPI with respect to the efﬁcacy outcome.
These analyses support the FDA’s conclusion that non-inferiority is not demonstrated for 
the efﬁcacy end point in REPLACE-2.
Noninferiority Analysis of REPLACE-2
Endpoint NI margin (odds ratio)
Odds ratio
(95% CI)
NI 
criterion
Fraction 
preservation
(95% CI)
NI 
criterion
Quadruple
(9.2 vs 
10%)
1.11 0.92 (0.77-1.09) Yes 1.21 (0.78 - 1.65) Yes
Triple
(7.6 vs 
7.1%)
1.21 1.09 (0.92-1.32) No 0.85 (0.51 - 1.20) Yes
923-146 Prolonged Heparin Exposure, Development of 
Thrombocytopenia, Use of GP IIb/IIIa Inhibitors, and 
History of Renal Dysfunction Predict Moderate or 
Severe Bleeding: A Report From the Complications 
After Thrombocytopenia Caused by Heparin (CATCH) 
Registry
Gustavo B. Oliveira, Kevin J. Anstrom, Emily F. Honeycutt, Charles S. Abrams, Richard 
C. Becker, Peter B. Berger, David J. Moliterno, Stephan Moll, Lawrence Rice, Neil 
Kleiman, Jo Ellen Rodgers, Steven R. Steinhubl, Victor F. Tapson, E. Magnus Ohman, 
Christopher B. Granger, Duke Clinical Research Institute, Durham, NC, University of 
North Carolina, Chapel Hill, NC
Background: The frequency and signiﬁcance of bleeding among patients (pts) treated 
with low-molecular-weight heparin (LMWH) or unfractionated heparin (UFH) are derived 
from clinical trials in acute coronary syndromes (ACS). In clinical practice, predictors 
of bleeding and its relationship with mortality in different settings are not well deﬁned. 
Methods: We analyzed the CATCH registry to determine the incidence of moderate/
severe bleeding. Multivariable logistic regression was applied to identify predictors of 
bleeding and its association with in-hospital death. Results: 2374 pts, age 65.2 yrs, 
44% women, hospitalized due to surgery (65%), ACS (12%), and heart failure (8.5%) 
(Mar’03-Apr’04). UFH was used in 52% (55% SC, 45% IV), LMWH in 40%, both in 8%. 
Median duration of heparin use was 7.7 (5.5-12.0) days. Bleeding occurred in 6.7%. 
After excluding CABG-pts, the model with predictors of bleeding was determined (Table). 
Although mortality was higher in pts with bleeding (9.4% vs. 2.4%, p<0.0001), after 
adjustment for important variables such as age and thrombotic complications, bleeding 
was not independently associated with mortality (OR, 1.71; 95% CI 0.84-3.48; p=0.13). 
Conclusions: Contemporary risk of bleeding is associated with duration of heparin 
therapy, GP IIb/IIIa inhibitors, baseline PLT, occurrence of signiﬁcant thrombocytopenia, 
and prior renal dysfunction. Despite the high mortality associated with this complication, 
bleeding was not an independent predictor of mortality.
Multivariable Model With Predictors of Non-CABG-Related Moderate or 
Severe Bleeding (c-index=0.66)
Variable χ² OR (95% CI) p-value
Treatment With GP IIb/IIIa Inhibitors 11.4 3.1 (1.6-6.0) 0.0007
Baseline PLT, per 10,000/mm³ 8.9 1.02 (1.00-1.04) 0.003
Duration of Heparin Therapy, per 1-day 5.7 1.01 (1.00-1.03) 0.02
Diastolic Blood Pressure, per 10mmHg 5.6 0.84 (0.72-0.97) 0.02
History of Renal Dysfunction 4.9 1.62 (1.06-2.5) 0.02
PLT Relative Drop ≥50% and <150,000/
mm³ 4.8 1.84 (1.06-3.2) 0.02
 
923-147 The Fate of Randomized Trials Presented at the 
American College of Cardiology Meeting 1999-2002: 
What Follows the 15 Minute Presentation?
Mustafa Toma, Finlay A. McAlister, Liza Bialy, Denise Adams, Ben Vandermeer, Paul W. 
Armstrong, University of Alberta Hospital, Edmonton, AB, Canada
Background: A large body of evidence has accumulated about the bias inﬂuencing the 
ultimate publication of abstracts at scientiﬁc meetings. However, no studies have focused 
on recent efforts designed to highlight particular research abstracts (such as the Late 
Breaking Trials Sessions) nor the degree to which these meeting abstracts align with 
subsequent full journal articles.
Thus we examined what proportion of randomized controlled trials (RCTs) presented 
at the American College of Cardiology (ACC) Meetings are subsequently published as 
full-length journal articles and evaluated the consistency between the meeting abstract 
content and corresponding full journal publication.
Methods: RCTs were identiﬁed by hand-search of the proceedings booklets for the 1999-
2002 ACC Meetings. Subsequent full manuscript publications were identiﬁed by a search 
of multiple electronic databases.
Results: The 86 RCTs presented at the Late Breaking Trials ACC sessions were more 
likely to be published (91% versus 69%, p<0.001), appear in high impact journals (86% 
versus 43%, p<0.0001), and were published earlier after presentation (median time 11.5 
months versus 22.0 months, p<0.0001) than 100 randomly selected RCTs presented at 
other ACC sessions. Late Breaking RCTs were larger (median 2737 patients versus 896 
patients, p<0.001), more likely to be US-based (56% versus 36%, p=0.007), had higher 
quality scores (mean Jadad score 2.69 versus 2.19, p=0.01), and were less likely to report 
favorable results than the other RCTs (45% versus 54%, p=0.01). The only signiﬁcant 
factors associated with eventual full journal publication were sample size and presentation 
at the Late Breaking Session (OR 3.44, p=0.006, after adjusting for trial size).
Conclusions: The peer reviewed ACC process for selecting Late Breaking Trials identiﬁes 
research that is more likely to be published, accepted in high impact journals, and is 
published earlier after presentation than RCTs presented at other sessions.
923-148 Distal Protection Devices During Percutaneous 
Coronary Intervention Are Effective in Reducing Death 
or Recurrent Myocardial Infarction in Saphenous Vein 
Grafts but Not in Acute Myocardial Infarction: A Meta-
analysis
Rehan Qayyum, Muhammad R. Khalid, Jurga Adomaityte, Stylianos P. Papadakos, 
Frank C. Messineo, Prudich Medical Center, Montcalm, WV, New York Hospital Queens, 
Flushing, NY
Background: The use of distal protection devices (DPD) during percutaneous catheter 
intervention (PCI) prevents distal embolization of plaque and thrombus and may improve 
outcomes. However, clinical trials have not found a consistent beneﬁt of DPD in all clinical 
settings.
Methods: We performed a meta-analysis of trials that examined the effects on death or 
recurrent acute myocardial infarction (AMI) of DPD within 30 days of PCI of saphenous 
vein grafts (SVG) without AMI and PCI for native vessel AMI (NVAMI). We identiﬁed 
randomized controlled clinical trials of DPD vs. no-DPD in patients undergoing PCI by 
searching PubMed, OVID, the Cochrane databases, references of articles, and abstracts 
of conference proceedings (all from 2000 to September 2005).
Results: Seven trials (patients = 2447) met the inclusion criteria. When all the studies are 
considered, death or AMI was less frequent with DPD use (relative risk ratio [RR] = 0.62, 
95% CI: 0.48, 0.80). In subgroup analysis, use of DPD during PCI of SVG was associated 
with a signiﬁcant decrease in the outcomes (RR = 0.61, 95%CI: 0.46, 0.80). Whereas use 
of DPD during PCI for NVAMI showed a trend towards a favorable outcomes (RR = 0.69, 
95% CI: 0.39, 1.22). The power of meta-analysis to detect a 30% reduction in the RR of 
endpoint during PCI for AMI was only 25% at alpha of 0.05.
Conclusions: Use of DPD decreases early death or recurrent AMI during PCI of SVG 
but not during PCI for NVAMI. However, the statistical power is not adequate to reject a 
beneﬁt of DPD during PCI for NVAMI.
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923-149 Combining Warfarin and Antiplatelet Therapy After 
Coronary Stenting in the Global Registry of Acute 
Coronary Events: Is it Safe and Effective to Use Just 
One Antiplatelet Agent?
Michael Nguyen, Yean L. Lim, Antony Walton, Jeffrey Lefkovits, Giancarlo Agnelli, 
Shaun G. Goodman, Andrzej Budaj, Dietrich C. Gulba, Jeanna Allegrone, David Brieger, 
GRACE Investigators, Western Hospital, Melbourne, Australia, Concord Hospital, 
Sydney, Australia
Background: The optimal regimen in terms of efﬁcacy and safety of combination 
warfarin/antiplatelet therapy following coronary stenting in acute coronary syndrome 
(ACS) needs further investigation. We describe factors that determine whether single or 
dual antiplatelet therapy is prescribed in patients who required warfarin following coronary 
stenting. We also investigated whether single (aspirin or thienopyridine) compared with 
dual antiplatelet therapy in combination with warfarin is associated with an excess of 
adverse outcomes.
Methods: We analyzed data from 592 patients in the multinational Global Registry of 
Acute Coronary Events who underwent coronary stenting following presentation with an 
ACS and were subsequently discharged on either warfarin and dual antiplatelet therapy 
(n=404) or warfarin and single antiplatelet therapy (n=188).
Results: Use of single antiplatelet therapy combined with warfarin was more common 
in Europe than in the USA (41% vs 20% of patients receiving warfarin/antiplatelet, 
P<0.001) and was more likely to be used in patients with a history of major surgery or 
trauma (54.5% received warfarin/single antiplatelet vs 45.5% warfarin/dual antiplatelet, 
P=0.02), however, other baseline characteristics were similar. Patients discharged on 
warfarin/single antiplatelet were less likely to receive unfractionated heparin (65.2% vs 
75.8%, P=0.008) or glycoprotein IIb/IIIa antagonists (47.3% vs 62.6%, P<0.001) while in 
hospital, but the use of low-molecular-weight heparin did not differ (53.3% warfarin/single 
antiplatelet vs 53.8% warfarin/dual antiplatelet, P=0.91). There was a trend towards less 
in-hospital bleeding in the warfarin/single antiplatelet group (4.8 vs 8.1%, P=0.16) with no 
difference in 6-month mortality or myocardial infarction.
Conclusion: The use of single compared with dual antiplatelet therapy in combination 
with warfarin following stent placement is common with signiﬁcant geographic variation. 
There was a strong trend towards reduced bleeding without excess mortality or myocardial 
infarction at 6 months in patients on warfarin and single antiplatelet therapy.
923-150 A Comprehensive Approach to the Development of Risk 
Adjustment Models for Fatal and Non Fatal Outcomes 
Following Contemporary PCI: A Report From the 
Blue Cross Blue Shield of Michigan Cardiovascular 
Consortium
Mauro Moscucci, Dean E. Smith, Eva M. Kline-Rogers, Michael O’Donnell, Kirit Patel, 
Sanjaya Khanal, Richard McNamara, David Share, Kim A. Eagle, for The Blue Cross 
Blue Shield of Michigan Cardiovascular Consortium (BMC2), University of Michigan 
Medical Center, Ann Arbor, MI
Background: Risk adjustment models for PCI mortality have been developed and 
validated, but there has been no comprehensive approach toward the development of 
models for fatal and non fatal outcomes.
Methods: Data were prospectively collected between 10/2002 and 12/2004 from 
43,024 PCI in a regional consortium. Outcomes evaluated included: In-hospital death, 
stroke, nephropathy requiring dialysis (NRD), any contrast nephropathy (CN), vascular 
complication (VC) and MACE (a combined of death, any CABG, repeat revascularization, 
stroke and MI). The data set was divided into a training set and a validation set. Model 
discrimination was determined using the C-statistic and goodness of ﬁt was assessed 
using the Hosmer-Lemeshow statistic.
Results: 22 variables were identiﬁed as essential for the development of all models. 
They included gender, age, diabetes, dialysis prior to PCI, history of GI bleeding, extra 
cardiac vascular disease, hypertension, history of CHF, atrial ﬁbrillation, prior history of 
PCI, COPD, emergency procedure, cardiac arrest, MI within 7 days, cardiogenic shock, 
creatinine >1.5 mg dl, ejection fraction< 50%, number of lesions treated, ACC/AHA type 
C lesion, left main stenosis, coronary calciﬁcation and 3 vessel disease. The C-statistic 
varied between 0.71 and 0.89 in the validation set, consistent with excellent model 
discrimination. 
Death Stroke NRD CN VC MACE
Training set
c-statistic 0.92 0.80 0.95 0.86 0.72 0.73
Hosmer-Lemeshow p-value 0.55 0.48 0.27 0.001 0.23 0.57
Validation Set
c-statistic 0.89 0.71 0.88 0.84 0.71 0.71
Hosmer-Lemeshow p-value 0.42 0.28 0.42 <0.001 0.72 0.09
Conclusions: A limited number of variables and resources appears adequate for 
developing a comprehensive risk adjustment strategy for PCI.
923-151 Improved Outcomes After In-Hospital Revascularization 
in the Elderly and Very Elderly with High-Risk Non-
ST-Elevation Acute Coronary Syndromes. The Global 
Registry of Acute Coronary Events
Gerard Devlin, Joel Gore, John Elliott, Álvaro Avezum, Kim A. Eagle, Frederick A. 
Anderson, Wei Huang, David Brieger, GRACE Investigators, Waikato Hospital, Hamilton, 
New Zealand, Concord Hospital, Sydney, Australia
Background Early angiography and revascularization are recommended in high-risk 
patients with acute coronary syndromes (ACS). Advanced age increases risk for cardiac 
events and during revascularization. The optimal treatment strategy for elderly ACS 
patients is debated.
Methods We report in-hospital and 6-month outcomes in young (Y), elderly (E, 70-80 yrs) and 
very elderly (VE, >80 yrs) patients admitted with high-risk non-ST-elevation (NSTE) ACS.
Results Data were available in 15,021 patients (28% E, 16% VE). E and VE patients 
were less likely to receive aspirin, beta-blockers and statins at discharge, and remained 
in hospital for longer (6 v 5 d, P<0.001). Angiography and revascularization were 
performed less commonly with advanced age. Multivariable analysis, adjusting for 
potential confounders, showed that 6-month survival was higher after revascularization 
in all groups, with a 59% mortality reduction in E patients (HR 0.41, 95% CI 0.29-0.59) 
and a 37% reduction in the VE (0.63, 0.45-0.89). Readmission rates were lower after 
revascularization in E. The incidence of stroke was not increased in the E or VE by 
revascularization. The 6-month triple endpoint (death/readmission/stroke) was reduced 
in the E and VE but not the Y. 
In-hospital treatment Y (<70 years)n=8,461
E (70-80 years)
n=4,140
VE (> 80 years)
n=2,420
Aspirin (%) 95 92 91
Beta-blocker (%) 87 80 79
Statin (%) 66 57 46
Angiography (%) 66 53 31
PCI (%) 37 27 17
CABG (%) 7.5 7.3 3.0
Outcomes (%) Revasc(n=3,661)
No revasc
(n=4,729)
Revasc
(n=1,368)
No revasc
(n=2,747)
Revasc
(n=461)
No revasc
(n=1,941)
In-hospital CHF/pulmonary edema 7.3 9.3P=0.001 14
21
P<0.0001 21
25
P=0.15
In-hospital arrhythmia 5.0 4.1P=0.06 14
13
P=0.21 14
16
P=0.28
6-month death 2.0 3.8P<0.0001 3.2
8.5
P<0.0001 11
19
P<0.001
Readmission for cardiac illness 17 16P=0.60 17
22
P=0.0001 23
27
P=0.12
6-month stroke 0.4 1.0P=0.002 1.7
1.3
P=0.36 2.1
3.0
P=0.33
6-month triple endpoint 18 19P=0.21 20
28
P<0.0001 31
39
P=0.001
Conclusion Revascularization in E and VE was associated with larger absolute 
reductions in death than in Y, but not with increased risk of 6-month stroke. Advanced age 
alone should not be regarded as a contraindication to invasive management of high-risk 
NTSE ACS.
923-152 Angiographic Success Rates With Chronic Total 
Occlusions - Little Change Despite a Decade of 
Experience
Thomas J. Ryan, Jr., John F. Robb, Mirle A. Kellett, Jr., Michael J. Hearne, Theodore M. 
Silver, William Phillips, Thomas P. Wharton, Winthrop D. Piper, David J. Malenka, Maine 
Medical Center, Portland, ME, Northern New England Cardiovascular Disease Study 
Group, Lebanon, NH
Introduction: With increasing operator experience and advances in technology, 
interventionalists are approaching more complex lesions including chronic total occlusions 
(TOC). We hypothesized that outcomes associated with PCI of TO have improved over time.
Methods: We used our Northern New England PCI Registry to identify patients 
undergoing non-urgent PCI of a TOC for treatment of stable angina from 1995-2004. 
TOC was deﬁned as a Type C lesion with a 100% stenosis. Exclusion criteria included 
prior CABG and left main stenosis ≥50%. Logistic regression was used to determine if 
angiographic success rates improved over time.
Results: Study criteria were met by 600 patients - 20% were women, 20% were ≥70, 
23% had diabetes, and 31% had multi-vessel disease. A TOC in the RCA was most 
frequently attempted (53.0%) followed by the LAD (26.3%) and CX (20.7%). There was 
an intervention in a second vessel in 16.3% of patients. The angiographic success rate 
(Table) was highest in the LAD and CX and lowest in the RCA. Adverse clinical outcomes 
were rare: in-hospital mortality 0.50%; emergency CABG 0.00%; MI 0.67%. Over time 
angiographic success rates for TOC improved signiﬁcantly for CX disease (ptrend=0.007) 
but did not for TOCs in the LAD or RCA distribution.
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Conclusions: TOC PCI can be performed safely and with a reasonable angiographic 
success rate. TOCs in the RCA are the most problematic. New approaches to TOC PCI 
are needed as there has been minimal improvement in success rates over time.
Angiographic Success Rates for Chronic Total Occlusions
(N) Overall 1995-1997 1998-2000 2001-2002 2003-2004 ptrend
LAD (%) (158) 77.2 73.9 81.6 76.0 76.6 0.790
RCA (%) (318) 66.4 61.5 65.2 67.4 69.3 0.397
CX (%) (124) 79.0 61.1 74.2 81.1 89.5 0.007
 
923-153 Financial Barriers to Health Care and Recovery After 
Acute Myocardial Infarction: A Prospective Registry 
Evaluating Myocardial Infarction: Event and Recovery 
(PREMIER) Study
Ali Rahimi, John Spertus, Kimberly J. Reid, Susannah Bernheim, Harlan M. Krumholz, 
Yale University School of Medicine, New Haven, CT, Cardiovascular Outcomes 
Research Consortium, Kansas City, MO
Background: Budgetary constraints have led to reductions in eligibility, increasing cost-
sharing and/or limiting insurance beneﬁts, but the prevalence and consequences of 
these ﬁnancial barriers are not well documented for patients with an acute myocardial 
infarction (AMI).
Methods: In PREMIER, an observational study of patients with AMI, we assessed 
ﬁnancial barriers to health care by examining self-reported avoidance of health care 
services or medication due to cost. Six-month outcomes for 2,498 individuals enrolled 
between January 2003 and June 2004 included health status symptoms (Seattle Angina 
Questionnaire (SAQ) angina frequency and quality of life), overall function (Short Form-12 
(SF-12) physical (PCS) and mental (MCS) subscores), rehospitalization, and mortality.
Results: The prevalence for reported ﬁnancial barriers, i.e. avoidance due to cost, to 
health care services or medication was 18.1% and 12.9%, respectively. In fully-adjusted 
6-month outcome analyses, including baseline health status, poorer health outcomes 
were present in those with both types of ﬁnancial barriers compared with those without 
ﬁnancial barriers. Individuals with ﬁnancial barriers to health care services had a 33% 
higher likelihood of angina (RR 1.33, 95% CI 1.1 to 1.58), a 5.8 point lower SAQ-quality 
of life score (p < 0.0001) and lower SF-12 PCS and MCS scores by 1.9 (p = 0.0038) and 
2.6 points (p < 0.0001), respectively. Individuals with ﬁnancial barriers to medication use 
had a 49% higher likelihood of angina (RR 1.49, 95% CI 1.25 to 1.77), an 8.5 point lower 
SAQ-quality of life score (p < 0.0001) and lower SF-12 PCS and MCS scores by 2.2 (p = 
0.0035) and 2.7 points (p < 0.0001), respectively. Financial barriers to medication were 
associated with a 35% higher hazard of all cause re-hospitalization (HR 1.35, 95% CI 
1.07 to 1.69) and a 43% higher hazard of cardiac re-hospitalization (HR 1.43, 95% CI 
1.03 to 1.99). There was no association with mortality at six-month follow-up.
Conclusions: Financial barriers are common and strongly associated with signiﬁcantly 
worse recovery after AMI, manifested as more angina, worse function, poorer quality of 
life and a signiﬁcantly higher risk of rehospitalization.
923-154 Treatment and Outcomes of Acute Coronary 
Syndromes Among 5,577 Patients Aged ≥90 Years: 
Results From the CRUSADE National Quality 
Improvement Initiative
Adam H. Skolnick, Eric D. Peterson, Karen P. Alexander, Anita Y. Chen, Matthew T. Roe, 
Charles V. Pollack, Jr., E. Magnus Ohman, John S. Rumsfeld, W. Brian Gibler, David J. 
Cohen, Beth Israel Deaconess Medical Center, Boston, MA, Duke Clinical Research 
Institute, Durham, NC
Background: Little is known about treatment and outcomes of acute coronary syndromes 
(ACS) in the growing cohort of the oldest old (age ≥90 y).
Methods: We examined presenting features, treatment, and in-hospital outcomes in pts 
with non-ST-segment elevation ACS aged ≥90 y from the CRUSADE Initiative (1/01-6/05).
Results: Among 142,335 qualifying pts, 5557 (4%) were ≥90 y; the mean age was 92.6 
± 2.6 y, most were female (67%), and relatively few had traditional risk factors (obesity 
8%, current smoking 3%, dyslipidemia 25%, and diabetes 20%). In contrast, comorbid 
conditions were frequent, including prior MI (33%), prior stroke (17%), CHF (39.3%) 
and renal insufﬁciency (21%). Mean time from symptom onset to hospital arrival was 
7.7 hrs; mean time from arrival to EKG was 46 min. Among eligible pts, aspirin, heparin, 
beta-blockers, and statins were given within 24 hrs to 91%, 75%, 81%, and 30% of pts, 
respectively. Catheterization contraindications were listed for 60% (40.6% due to pt 
age, 29.3% DNR, 12% pt refusal, 18.1% other). Only 19.1% without contraindications 
underwent catheterization, and 12.6% had revascularization. Adverse outcomes were 
common (see Figure).
Conclusion: In this large ACS population age ≥90, traditional risk factors were infrequent, 
while comorbidity was high. Use of early medical therapy and invasive care was low, 
and adverse outcomes were common. Earlier identiﬁcation and clariﬁcation of optimal 
management of ACS in the oldest old may mitigate their acute morbidity and mortality. 
923-155 In-Hospital Outcomes in Patients With ACS Treated 
With Sirolimus and Paclitaxel Drug Eluting Stents: 
Experience From the ACC-NCDR Database
Emir Veledar, Ralph Brindis, Paul Kolm, LLoyd Klein, Zefeng Zhang, Kathleen Hewitt, Olga 
Novik, Sunil Rao, Emir Fazlibegovic, Kristi Mitchell, William Weintraub, Emory University, 
School of Medicine, Atlanta, GA, Christiana Care Health Services, Newark, DE
Background: PCI with sirolimus and paclitaxel drug eluting stents (DES) in the setting 
of STEMI and NSTEMI ACS is becoming more common despite relatively scarce clinical 
trial data.
Methods: Outcomes and baseline clinical characteristic in ACS patients receiving 
sirolimus and paclitaxel DES were compared using data from ACC-NCDR database from 
3/04-12/04, divided into PCI within and after 24 hours of presentation.
Results: The database included 19,654 ACS patients with PCI with 24 hours (8,023 
sirolimus, 11,631 paclitaxel) and 22,970 ACS patients with PCI after 24 hours (9,255 
sirolimus and 13,715 with paclitaxel). The differences in clinical characteristics and 
outcomes between the Sirolimus and Paclitaxel stents was negligible for both time 
periods. Results are shown in the table.
Conclusions: For PCI performed both early and late after ACS presentation the clinical 
characteristics and in-hospital outcomes of those receiving sirolimus versus paclitaxel 
stents are very similar. The excellent clinical outcomes strongly support the use of DES in 
acute coronary syndromes despite potential theoretical concerns of placing these stents 
within a thrombotic milieu. 
PCI < 24 Hours After Onset vs. PCI > 24 Hours After Onset
Sirolimus Paclitaxel P- value Sirolimus Paclitaxel P- value
Number of Patients 8023 11631 9255 13715
Age 62.3±13.0 62.8±12.7 0.0065 64.5±12.3 64.9±12.2 0.0575
BMI 29.4± 5.8 29.3±5.7 0.2203 29.8± 6.0 29.7±5.9 0.8659
Female Gender 32.74% 33.27% 0.4406 36.55% 36.6% 0.9443
Shock at PCI 3.15% 3.09% 0.8021 0.7% 0.66% 0.7435
Angiographic success 93.07% 93.77% 0.0524 94.2% 94.13% 0.8409
Unplaned CABG 0.15% 0.21% 0.4001 0.11% 0.16% 0.3683
In-hospital mortality 1.66% 1.54% 0.5233 0.63% 0.59% 0.7294
Length of Stay 3.5±3.3 3.6±3.5 0.8745 2.7±3.1 2.7±3.2 0.2289
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946-145 The Oldest Old Patients Have a Lower Chance for 
Receiving Guidelines Recommended Atrial Fibrillation 
Therapy. The Experience of the Euro Heart Survey on 
Atrial Fibrillation
Stefano Fumagalli, Robby Nieuwlaat, Lorenzo Boncinelli, Panos E. Vardas, John Camm, 
Harry J. Crijns, the Euro Heart Survey Investigators, University and AOU Careggi, 
Florence, Italy, University Hospital, Maastricht, The Netherlands
Background: Atrial ﬁbrillation (AF) is the most common arrhythmia in the elderly, who are 
highly exposed to its associated adverse outcomes. We evaluated the inﬂuence of advanced 
age on the management and outcome of AF patients (pts) in “real life” practice.
Methods: The Euro Heart Survey on AF enrolled 5,333 pts with AF in 182 centres among 
35 European countries, in 2003 and 2004. Clinical characteristics, management and 
outcome data were collected at baseline and at 1 year follow-up. Results are reported 
according to three age-groups: <65 years (n=2,124); 65-80 years (n=2,534); >80 years 
(Oldest Old, n=671).
Results: The proportion of women (31 vs 47 vs 61%), heart failure (29 vs 35 vs 46%), 
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chronic obstructive pulmonary disease (9 vs 16 vs 21%), prior stroke/TIA (6 vs 12 vs 
18%), renal failure (3 vs 7 vs 12%) and permanent AF (21 vs 32 vs 47%) were highest 
in the Oldest Old pts (all with p<0.001). When selecting pts with high risk for stroke, 
oral anticoagulation (OAC) was less often prescribed in the oldest group (65 vs 68 vs 
52%; p<0.001). Multivariable analysis, limited to the Oldest Old pts revealed that OAC 
prescription, with ﬁrst detected AF as reference category, was more likely in persistent 
AF (p=0.033), but not in paroxysmal (p=0.123) and permanent AF (p=0.414). In addition, 
the use of OAC showed regional differences, with a higher prescription rate in Western 
countries compared to Central and Mediterranean ones (p=0.009). In symptomatic pts, 
the use of pharmacological and electrical cardioversion during the acute phase dropped 
with age (38 vs 37 vs 25%, and 25 vs 23 vs 15%; both p<0.001). During 1 year follow-up, 
the Oldest Old pts most often reached the combined endpoint of death, thromboembolism 
and bleeding (7 vs 10 vs 22%; p<0.001). Women (p=0.022) and pts receiving OAC 
(p=0.018) were less likely to reach the combined endpoint in multivariable analysis.
Conclusions: OAC is underused in old AF pts, despite their high risk for stroke and 
the proven efﬁcacy of the therapy in these pts. In addition, cardioversions are avoided 
in the elderly. In general, the management of old AF pts seems limited by age-oriented 
prejudices.
946-146 Improved Prescription of Evidence-Based Medications 
and Maintenance of High Adherence to These 
Medications in Acute Coronary Syndrome Patients 
After Implementation of Guidelines Applied in Practice
Reza Fazel, Debabrata Mukherjee, Fadi Saab, Niquole May, Eva Kline-Rogers, Bruce 
Rogers, Jianming Fang, Steven Erickson, Kim A. Eagle, University of Michigan, Ann 
Arbor, MI, Emory University, Atlanta, GA
Background: The ACC’s Guidelines Applied in Practice (GAP) program has been 
shown to increase prescription of evidence-based medications (EBM) in patients with 
acute coronary syndromes (ACS). However, the impact of GAP on patient adherence 
is unknown.
Methods: Quality initiatives based on GAP have been implemented at the University of 
Michigan Hospital since 1997. We identiﬁed 1,948 consecutive ACS patients admitted 
to the University of Michigan Hospital between May 1999 and April 2004. In order to 
assess prescription rates of EBM (aspirin, beta-blockers, ACE inhibitors, statins) in ACS 
patients, we created a composite score deﬁned by the number of these drugs prescribed 
at discharge divided by the number indicated for each patient. Data obtained by phone 
call at 6-12 months after discharge was used to create a similar composite score to 
assess patient adherence to EBM. Linear regression of composite scores versus time 
was used to assess temporal trends.
Results: The mean age of subjects was 63 (+ 13) years and 1,246 (64%) were male. 
Prescription of EBM at discharge improved steadily (P= 0.003 for change over time). 
There was a non-signiﬁcant trend for improvement in patient adherence (P=0.17), 
however, adherence was very high to begin with.
Conclusion: The GAP program resulted in steadily improving prescription rates of 
EBM at discharge and overall adherence at follow-up. However, the proportion of non-
adherence remained unchanged. Further studies are needed to clarify mechanisms of 
non-adherence.
 
Composite score for: 1999 2000 2001 2002 2003 P-value for trend 
Medications prescribed at 
discharge
(mean + s.d.)
0.70
+ 0.25
0.74
+ 0.24
0.78
+ 0.24
0.84
+ 0.18
0.85
+ 0.22 0.003
Medications still taken at
follow-up
(mean + s.d.)
0.87
+ 0.22
0.89
+ 0.21
0.89
+ 0.20
0.88
+ 0.22
0.89
+ 0.20 0.17
 
946-147 Cardiology Specialty Care is Associated With Higher 
Quality Performance for Patients Admitted With Heart 
Failure
Robert D. Grande, Cecelia K. Montoye, Anthony C. DeFranco, Jianming Fang, Todd M. 
Koelling, University of Michigan, Ann Arbor, MI
Background: Community hospitals participating in the ACC Mid-Michigan Guidelines 
Applied in Practice - Heart Failure (GAP-HF) initiative have demonstrated signiﬁcant 
improvement in quality of care measures in patients hospitalized with heart failure (HF). It 
is not understood what individual patient care characteristics inﬂuence the quality of care 
delivered to HF patients.
Methods For the 3639 patients studied in GAP-HF, a HF quality score (HFQS) was 
calculated as the proportional adherence to each of 13 separate HF quality measures 
(LV function assessment, appropriate use of ACE inhibitor or alternative, beta blocker, 
aldosterone inhibitors, and warfarin, pneumococcal vaccine, smoking cessation advice, 
and instruction for diet, daily weight monitoring, activity level, medications, symptom 
changes, and follow-up plan). Patient demographics, clinical characteristics, and 
hospitalization variables were entered into a multivariable logistic regression model using 
stepwise selection to determine independent predictors of high HFQS (≥ median).
Results: The median HFQS for the population (age 74 ± 13 years, 54% female, 49% 
with EF < 40%) was 0.64 (IQR 0.36 - 0.80). HFQS was higher for patients treated by a 
cardiology specialist than patients treated by a primary care physician alone (0.61 vs 
0.42, p<0.0001). Logistic regression analysis revealed that age, female gender, LVEF ≥ 
40%, lower blood pressure, arrival to hospital between 12pm and 4pm, discharge on a 
weekday, ICU requirement, dialysis requirement, presence of pneumonia, and presence 
of dementia were all independent predictors of lower HFQS, while care that included a 
cardiology specialist predicted higher HFQS (OR 2.27, 95%CI 1.21 - 4.25, p= 0.01). AUC 
for the ﬁnal multivariable model = 0.708.
Conclusions: Derivation of a predictive model for HF quality of care suggests that 
attention be paid to speciﬁc populations of patients with HF, including females, patients 
with preserved EF and patients arriving in the middle of the day or discharged during a 
weekday. Involvement of cardiology specialty care may help to improve the overall quality 
of care of HF in community hospitals.
946-148 Differences in Improvement in Reliability of Care 
by Patient Age, Race, and Gender in Get With the 
Guidelines Coronary Artery Disease
Kenneth A. LaBresh, Gregg C. Fonarow, Jyotsna Mulgund, David Goff, A. Gray Ellrodt, 
GWTG Steering Committee and Investigators, MassPRO, Waltham, MA, UCLA, Los 
Angeles, CA
Background: Get With The Guidelines (GWTG) is associated with increasing quality 
of care over time as indexed by a composite measure of ideal care. The degree of 
improvement as a function of pt age, gender and race/ethnicity is less well understood .
Methods: GWTG employed a collaborative model and web-based tool for data collection 
and decision support. Baseline data, 30 records per hospital and quarterly data for 7 
measures: early and dc ASA and beta blockers, dc ACEI for AMI, smoking cessation, and 
lipid lowering Rx if LDL> 100 mg/dL were analyzed. A composite measure was deﬁned as 
% of pts receiving all measures for which they were eligible. Odds ratios for the interaction 
of time and subgroups were calculated using a logistic regression model
Results: Data from 297 hospitals and 157,106 pts demonstrate signiﬁcant composite 
measure improvement over 8 quarters in all groups. Differences by age < or > 65 or gender 
were seen at baseline and did not change over time. The treatment rate at baseline was 
similar for African-Americans (AA) and Caucasians (C), with greater improvement in the 
C group, resulting in an increasing disparity over time.
Conclusions: GWTG hospitals signiﬁcantly improve care of pts regardless of age, 
gender, or race as reﬂected by a composite measure of ideal care. Disparities by age and 
gender did not change, but increased by race for AA compared to C. Despite substantial 
improvement with GWTG more work is needed to enhance both effectiveness and equity 
in care delivery. 
Group 
Comparisons Within Group
Odds 
Ratio Lower Upper Baseline Q4 Q8 p value
Composite Measure Overall 46.2% 59.3% 62.6% <0.0001
Age: > 65 vs.
<65 Age, Time Interaction 0.97 0.94 0.99
46.0%
46.7%
59.0%
59.9%
61.8%
63.3% 0.011
Gender: Male vs.
Female
Gender, Time 
Interaction 1.22 1.19 1.25
47.7%
44.0%
61.6%
55.8%
64.4%
59.2% <0.0001
African-American vs. 
Caucasian
Baseline
Q4
Q8
0.97
0.85
0.75
0.89
0.73
0.61
1.05
0.99
0.93
49.7%
48.6%
58.8%
61.3%
57.6%
64.5% =0.0008
 
946-149 Clinical Outcomes of Patients Undergoing 
Percutaneous Coronary Intervention on Weekends as 
Compared With Weekdays
Igor Mamkin, Rachid A. Elkoustaf, Haris Athar, Sarkis B. Baghdasarian, Anuj Shah, 
Patrick Campbell, Jeffrey F. Mather, Krista Maloney, Francis J. Kiernan, William E. 
Boden, Raymond G. McKay, Henry Low Heart Center, Hartford Hospital, Hartford, CT, 
University of Connecticut Health Center, Farmington, CT
Background: Patients with serious medical conditions have a higher mortality if they are 
hospitalized on a weekend than if they are admitted on a weekday. Our study compares 
in-hospital and nine-month clinical outcomes in patients undergoing weekend PCI versus 
those undergoing PCI on weekdays in a large, single center tertiary hospital with 24-hour 
PCI availability.
Methods: We analyzed 3086 consecutive patients (mean age - 63.7 yrs, males - 70.2%) 
undergoing either weekday (n=2737) or weekend (n=349) PCI. The study group included 
2212 patients with acute coronary syndromes (ACS) (71.6%), including ST-segment 
elevation myocardial infarction (STEMI) (n= 645, 20.9%), non-STEMI (n=706, 22.9%), 
unstable angina (n=800, 25.9%) and cardiogenic shock (n=61, 2.0%). Nine-month clinical 
follow-up was available in 96.2% of patients.
Results: Weekend PCI was not associated with either increased mortality or increased 
major adverse cardiac events (MACE) (table below). Compared with weekday PCI, 
weekend patients had a higher incidence of STEMI (44.7% vs 17.9%, p<0.01) and non-
STEMI (31.8% vs 21.7%, p<0.01), increased use of glycoprotein IIb/IIIa inhibitors (81.7% 
vs 67.3%, p<0.01) and adjunctive thrombolytic therapy (14.3% vs 6.6%, p<0.01), and a 
lower left ventricular ejection fraction (49% vs 51%, p<0.01). 
In-Hospital and 9-month Outcomes
Variable Weekday(n=2737)
Weekend
(n=349) p value
In-Hospital Outcomes
Death 1.5% 2.1% 0.47
Emergent CABG 0.2% 0.0% 0.42
Emergent Repeat PCI 0.2% 0.0% 0.42
Stroke 0.3% 0.0% 0.38
Contrast Nephropathy 1.0% 0.0% 0.10
Transfusion 5.0% 4.9% 0.97
Outcomes at 9 months
Death 3.8% 4.0% 0.91
Recurrent MI 1.8% 0.9% 0.22
Repeat Target Vessel PCI 3.1% 4.0% 0.39
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Conclusions: In spite of higher procedural acuity, weekend PCI is not associated with 
any increase in in-hospital or nine-month mortality or MACE compared to patients 
undergoing weekday intervention.
946-150 Practice Makes Perfect: ACC/AHA Guideline Adherence 
Is Higher in Hospitals With High Acute Myocardial 
Infarction Volume
William R. Lewis, Suzanne A. Sorof, Dennis M. Super, MetroHealth Campus, Case 
Western Reserve University, Cleveland, OH
Background: Treatment guidelines for patients with acute myocardial infarction (AMI) 
have been published by the AHA and ACC. Adherence to guidelines in several studies 
has been suboptimal. Several factors are associated with improved performance 
including quality improvement programs and teaching status. Studies demonstrating 
that AMI patient volume is associated with improved adherence are limited. Hypothesis: 
Adherence to published guidelines will improve with increased AMI patient volume.
Methods: The Centers for Medicare and Medicaid Services developed the Hospital 
Compare (HC) database which is the result of voluntary submission of data by acute care 
hospitals. We compared HC data from January to June of 2004. The percent compliance 
was recorded for 6 clinical measures [Aspirin (ASA) and beta blocker (BB) use on 
admission (a) and discharge (d), ACE inhibitor for LV dysfunction (ACE) and smoking 
cessation counseling (TOB)] for patients admitted with the diagnosis of AMI. Groups were 
assigned based quartiles of AMI volume. Comparisons were made between quartiles of 
AMI volume using ANOVA for each clinical measure.
Results: 3712 hospitals reported data to the HC database. Mean adherence is reported 
for each quartile and each parameter: 
Parameter Quartile 1 Quartile 2 Quartile 3 Quartile 4 P value
ASA a 83.8% 91.3% 93.8% 94.9% <0.001
ASA d 77.3% 84.2% 89.4% 93.3% <0.001
BB a 71% 83% 88.3% 90% <0.001
BB d 73.4% 81.5% 88.6% 91.1% <0.001
ACE 70.7% 70.7% 76.2% 78.8% <0.001
TOB 57.2% 64.6% 74.7% 81.5% <0.001
Conclusion: Guideline adherence improves as the AMI volume increases. Larger centers 
may have more resources available to assure AMI quality. Practice makes perfect.
946-151 The Association Between Hospital Guideline 
Adherence, Dosing Safety, and Patient Outcomes: 
Results From the CRUSADE Quality Improvement 
Initiative
Eric D. Peterson, Anita Y. Chen, Karen P. Alexander, Nancy M. Allen LaPointe, Elizabeth 
S. Fraulo, L. Kristin Newby, Matthew T. Roe, W. Brian Gibler, E. Magnus Ohman, Duke 
Clinical Research Institute, Durham, NC
Background: Quality metrics currently focus on the use of guidelines-indicated 
medications without considering their dosing. Limited knowledge exists regarding the 
correlation between guidelines compliance and dosing safety or their additive impact on 
patient (pt) outcomes.
Methods: We studied 56,245 pts from CRUSADE with non-ST-segment elevation acute 
coronary syndromes at 318 hospitals from 1/04 to 7/05. Analysis was limited to centers 
with ≥40 cases. We determined hospitals’ compliance with 9 ACC/AHA guidelines-
recommended therapies in eligible pts and their dosing safety as the percentage of pts 
whose initial dose of heparin or glycoprotein IIb/IIIa exceeded recommended dose based 
on weight and creatinine clearance. The impact of superior (> mean) or inferior (< mean) 
performance on patient mortality was determined for each combination of metrics.
Results: Rates of guidelines compliance (IQR: 77%, 86%) and dosing safety (IQR: 47%, 
66%) varied considerably among hospitals, with limited hospital level correlation between 
the 2 metrics (r = 0.21). However, mortality rates were inversely associated with both 
guidelines compliance and safety metrics (p < 0.001 for both). Hospitals with superior 
performance on both metrics had lowest pt mortality (p<0.0001, Figure).
Conclusions: The limited correlation between guidelines compliance and drug safety 
suggests the need for both metrics. Lowest mortality rates are achieved at hospitals that 
excel in both, as the best indicator of effective care.
946-152 ACC/AHA Performance Measures for Patients 
Hospitalized With HF: Are They Predictive of Clinical 
Outcomes?
Gregg C. Fonarow, William T. Abraham, Nancy M. Albert, Karen Chiswell, Wendy Gattis 
Stough, Mihai Gheorghiade, Barry Greenberg, Christopher O’Connor, Jie-Lena Sun, 
Clyde Yancy, James B. Young, OPTIMIZE-HF Investigators and Hospitals, UCLA, Los 
Angeles, CA
Introduction: Quality improvement efforts in heart failure (HF) have focused on the 
development of performance measures with the assumption that these performance 
processes directly impact clinical outcomes, however, this link remains largely untested.
Methods: OPTIMIZE-HF is a registry/performance improvement program for pts 
hospitalized with HF. 60-90 day post-discharge (dc) follow-up (f/u) data were prospectively 
collected in a pre-speciﬁed 10% sample. Multivariable and/or propensity adjusted 
analyses were performed for each performance measure in eligible patients.
Results: 5,791 patients from 91 hospitals were included in this analysis. Mean patient 
age was 72.0 years, 51% were males, 78% Caucasian, with ischemic etiology in 42%. 
Mortality during f/u was 8.6% and death/re-hosp 36.2%. Of the 5 HF performance 
measures, none were signiﬁcantly associated with early mortality risk and only ACEI/
ARB was related to death/re-hosp. β-blockade at the time of hospital dc, currently not 
a HF performance measure, was strongly associated with reduced risk of mortality and 
mortality/re-hosp during f/u.
Conclusions: Current HF performance measures have little relationship to patient 
outcomes in the ﬁrst 60-90 days post dc. In contrast, β-blockade use has by far the 
strongest process outcome link, making it ideal for inclusion as a HF hospital performance 
measure.
Table 1: Process Outcome Link for ACC/AHA Hospital Performance 
Measures for HF
Predictive of Mortality at 60-90 
Day F/U
Predictive of Death/Rehospitalization at 
60-90 Day F/U
Performance Measure
N,% HR
95% HR 
Conﬁdence 
Limits
P Value HR 95% HR Conﬁdence Limits P Value
HF-1 Discharge Instructions
2653/4010
66%
0.932 .702, 1.238 0.6267 1.048 0.882, 1.246 0.5944
HF-2 Evaluation of LV 
Systolic Function
4166/4664
89%
0.910 .640, 1.294 0.6003 1.033 0.834, 1.280 0.7665
HF-3 ACEI/ARB at Discharge 
for LVD
1579/1877
84%
0.803 0.420, 1.537 0.5084 0.586 0.433, 0.0005 0.0005
HF-4 Smoking Cessation 
Counseling
612/853
72%
0.643 0.349, 1.185 0.1571 0.750 0.495, 0.1733 0.1733
HF-5 Warfarin for Atrial 
Fibrillation
836/1590
53%
0.715 0.478, 1.071 0.1035 0.862 0.685, 0.2067 0.2067
β-Blocker at Discharge
1718/2021
85%
0.46 0.33, 0.66 <0.0001 0.67 0.53, 0.0004 0.0004
 
946-153 Patient Safety Suffers at Nursing Shift Changes: Error 
Rate Peaks for Intravenous Unfractionated Heparin 
Administration
John Fanikos, Jon Silverman, Catherine Saniuk, Carol Luppi, Samuel Z. Goldhaber, 
Brigham and Women’s Hospital, Boston, MA
Background: Smart infusion pump drug libraries limit and guide the input and delivery of 
intravenous (IV) medications. We studied whether drug libraries can detect dosing error 
patterns with IV unfractionated heparin (UFH). To improve patient safety, we identiﬁed 
peak and trough UFH error rates.
Methods: The library electronically records attempted programming of UFH overdoses, 
underdoses, and duplicate drug doses. We reviewed all UFH alerts from October 2003 
through January 2005.
Results: During the study period, 3,674 patients received UFH. 501 alerts were generated 
on 246 patients. Alerts occurred most frequently between 2 P.M. and 4 P.M. [94 of 501 
alerts (18.8%)]. The lowest occurrence of alerts was from 4 A.M. to 6 A.M. [15 (3.0%)] 
(Figure). Overdose alerts occurred more frequently [250 alerts (49.9%)] than underdose 
alerts [178 (35.5%)] or duplicate drug therapy alerts [73 (14.6%)]. After an alert was 
generated, the users either reprogrammed the device with a new volume, dose, or rate 
[279 (64.1%)] or canceled the infusion [156 (35.9%)].
Conclusions: Peak error time for UFH administration corresponds to our nursing shift 
change. Whether these errors are caused by nursing fatigue, haste in completing the 
routine tasks, communication failures, requires study. Additional resources should 
be allocated to enhance patient safety at nursing shift change. Smart infusion pump 
technology markedly reduces errors in UFH drug administration and may be useful for 
broad dissemination in the hospital setting.
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946-154 The Relationship Between Health Insurance and Long-
Term Health Status Among Acute Myocardial Infarction 
Survivors: Results From the PREMIER Registry
Alexander Georgakis, John Spertus, Kimberly J. Reid, Harlan M. Krumholz, Eric D. 
Peterson, Susannah Bernheim, David J. Cohen, Beth Israel Deaconess Medical Center, 
Boston, MA, Cardiovascular Outcomes Research Consortium, Kansas City, MO
Background: Although previous studies have suggested that health insurance (INS) has 
little direct impact on post-acute myocardial infarction (AMI) survival, the impact of INS on 
health status and quality of life is unknown.
Methods: We examined the relationship between INS and follow-up health status among 
patients aged < 65 who were enrolled in PREMIER, a 19-center prospective study of 
hospitalized AMI survivors. Among 1472 patients, 266 (18%) were uninsured. Primary 
outcomes included 6-month cardiovascular and general health status as measured by 
the Seattle Angina Questionnaire (SAQ) and the SF12. Multivariable linear or Poisson 
regression models were used to adjust for baseline health status, comorbidities, in-
hospital complications, and inpatient therapies.
Results: Uninsured patients were younger (50 vs 53 years) and more likely to be non-
white (48% vs 27%) and smokers (58% vs 43%). There were no signiﬁcant differences 
in hospital care between the two groups. Between discharge and six months, uninsured 
patients were less likely to participate in cardiac rehabilitation (47% vs 72%), use statins 
(60% vs 70%) or �-blockers (62% vs 76%), and have a healthcare provider (69% vs 91%; 
all p<0.001). After adjustment, lack of insurance was associated with worse 6-month 
health status across several domains (Table).
Conclusion: Lack of INS is associated with poor post-AMI health status. Reduced access 
to cardiac rehabilitation, cardiac medications, and providers may mediate these disparities. 
Crude and Risk Adjusted Relationship Between Health Insurance  
and 6-Month Health Status after AMI
Crude impact of insurance Adjusted impact of insurance
Outcome Odds Ratio(95% CI) P-value
Odds Ratio
(95% CI) P-value
Presence of any physical
limitation due to angina 0.74 (0.56-0.98) 0.0366 0.87 (0.62-1.20) 0.3858
Any angina 0.71 (0.58-0.87) 0.0011 0.82 (0.66-1.02) 0.0754
Poor treatment satisfaction
(lowest quartile) 0.92 (0.87-0.97) 0.0012 0.94 (0.89-0.99) 0.0125
Raw ∆
(95% CI) P-value
Raw ∆
(95% CI) P-value
SAQ Quality of Life 7.5 (4.3-10.6) <0.0001 4.6 (1.5-7.7) 0.0036
SF-12 Physical
Component Score 3.6 (1.7-5.5) 0.0002 2.7 (1.0-4.3) 0.0019
SF-12 Mental
Component Score 2.1 (0.5-3.7) 0.0094 0.85 (-0.7-2.4) 0.2727
 
946-155 Health Status and Clinical Outcomes After Myocardial 
Infarction at One-Year: A Comparison Between Patients 
Hospitalized With ST-Elevation Versus Non-ST-Elevation 
Myocardial Infarction
Sanjaya Khanal, Rasha Bazari, Michael Tucciarone, Kimberly J. Reid, William S. 
Weintraub, Harlan M. Krumholz, John A. Spertus, Henry Ford Hospital, Detroit, MI, 
Cardiovascular Outcomes Research Consortium, Kansas City, MO
Background: As the mortality after myocardial infarction (MI) improves, health status 
outcomes of patients with ST-elevation (STEMI) and non-ST-elevation (NSTEMI) MI will 
be increasingly relevant. We compared clinical and health status outcomes between 
patients with STEMI vs NSTEMI enrolled in the PREMIER-QI study.
Methods: In a 19-center prospective study between 1/2003 and 6/2004, 1960 patients 
were followed for one year. Clinical and health status outcomes were compared between 
patients with STEMI vs NSTEMI. Multivariate models adjusted for baseline differences 
including demographics, disease severity, and therapy.
Results: 915 (47%) had STEMI and 1045 (53%) had NSTEMI. Baseline comorbidities 
were signiﬁcantly different between the groups. While Kaplan Meier estimates for mortality 
(p<0.001) was worse for patients with NSTEMI at one year, the type of MI was not an 
independent predictor of mortality (HR 1.00, 95% CI 0.67-1.49) in fully adjusted models. 
While SAQ scores for health status were worse for the NSTEMI group at baseline; at 
six-months and one year, only scores for physical limitation was worse for patients 
with NSTEMI (Table1). MI type was not an independent predictor of SAQ health status 
outcomes after multivariate adjustment.
Conclusions: The comorbidities and health status in patients with NSTEMI and STEMI 
are signiﬁcantly different at presentation. NSTEMI vs STEMI was not an independent 
predictor of clinical or health status outcomes at one year post MI. 
Table 1: Seattle Angina Questionnaire Scores in STEMI vs. NSTEMI 
(Mean±SD or %)
Variable STEMIN=951
NSTEMI
N=1045 p-value
Any Angina at Admission 47.5% 58.3% <0.001
Any Physical Limitation due to Angina at Admission 35.7% 52.4% <0.001
Quality of Life at Admission 65±23 61±34 <0.001
Any Angina at 6-months 21.4% 24.4% 0.12
Any Physical Limitation due to Angina at 6-months 18.5% 24.9% 0.003
Quality of Life at 6-months 83±19 84±20 0.59
Any Angina at 1-year 18.3% 21.3% 0.10
Any Physical Limitation due to Angina at 1-year 14.9% 19.6% 0.02
Quality of Life at 1-year 84±17 85±19 0.46
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811-3 Driving Times and Distances to Hospitals With 
Percutaneous Coronary Intervention in the U.S.: 
Implications for Pre-Hospital Triage of Patients With ST-
Elevation Myocardial Infarction
Brahmajee K. Nallamothu, Eric R. Bates, Venkat Polavarapu, Yongfei Wang, Elizabeth 
H. Bradley, Harlan M. Krumholz, University of Michigan, Ann Arbor, MI, Yale University, 
New Haven, CT
Background: The success of pre-hospital triage protocols for patients with STEMI 
will depend on how patients are geographically distributed around PCI hospitals. We 
determined timely access to PCI hospitals in the US.
Methods: Our data sources were the 2001 American Hospital Association Survey and 
the 2000 US Census. From US census tracts, driving times and distances to the nearest 
PCI and non-PCI hospitals for the US adult population were calculated using a nationwide 
road network. We then determined the proportion of adults that lived within a 60 min 
pre-hospital time period of a PCI hospital. Among those with a non-PCI hospital as the 
nearest facility, we also determined the proportion that required additional transport times 
≤30 mins if directly referred to a PCI hospital (ie, bypassing the non-PCI hospital).
Results: Median times and distances to the nearest PCI hospital for the population were 
11.4 (IQR, 5.7-28.5) mins and 8.0 (IQR, 3.5-22.4) miles, respectively. A total of 78.9% of 
adults lived within a 60 min pre-hospital time period of a PCI hospital (Figure). Among 
those with a non-PCI hospital as the nearest facility, 74.0% required additional transport 
times ≤30 mins if directly referred to a PCI hospital. Estimates varied substantially across 
urban, suburban and rural areas.
Conclusion: Most US adults lived within a 60 min pre-hospital time period. Even among 
those closer to non-PCI hospitals, direct referral to a PCI hospital with ≤30 mins of 
additional delay appeared possible for many individuals.
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811-6 Compliance With Contemporary Guidelines for Non-
ST-Elevation Acute Coronary Syndromes: Inﬂuence on 
Outcome and Interaction With Risk Stratiﬁcation
Carlos T. Aguiar, Jorge S. Ferreira, Investigators Portuguese Registry of ACS, Hospital 
Santa Cruz, Carnaxide, Portugal
Background: Several risk markers have been proposed to guide clinical decision making, 
predict prognosis, and direct appropriate management strategies for patients (pts) with 
non-ST-elevation acute coronary syndromes (NSTE-ACS). The purpose of this study is 
to evaluate the impact of compliance with treatment guidelines on outcome of unselected 
NSTE-ACS pts, and whether current risk stratiﬁcation markers interact with the effect of 
guideline compliance on pt outcomes.
Methods: Pts with NSTE-ACS enrolled in a nationwide prospective registry since 2002 
were eligible. Compliance with guidelines was assessed with a 6-point scale based on the 
aggregate use of aspirin, clopidogrel, heparin, beta-blockers, ACE inhibitors, and statins. 
Study endpoint is in-hospital all-cause mortality.
Results: Study population consisted of 7577 pts, in whom average guideline compliance 
score was 4.6±1.2 points. Compliance was better for aspirin (96%) and heparin (97%), 
than for statins (81%), beta-blockers (72%), ACE inhibitors (69%) or clopidogrel (49%). 
Overall in-hospital mortality was 2.5%. Compliance score was signiﬁcantly lower among 
pts who died (3.9±1.2 vs 4.7±1.1 points; p<0.001), and independently predicted the risk 
for in-hospital death (adjusted OR for each point increase = 0.68; 95% CI, 0.60-0.78; 
p<0.001). The effect of the guideline compliance score on the study endpoint was not 
signiﬁcantly inﬂuenced by any of the following (p=ns for all interaction tests): gender, 
diabetes, prior history of multiple territory atherothrombotic disease, TIMI risk score, Killip 
class on admission, troponin elevation, and in-hospital revascularization. A compliance 
score of 6 independently predicted in-hospital mortality (adjusted OR compared to 
score<6 = 0.30; 95% CI, 0.17-0.56; p<0.001). Pts who received a GP 2b/3a inhibitor in 
addition to all other 6 therapies did not derive signiﬁcant additional prognostic beneﬁt 
when compared to those receiving the 6 therapies only (OR for in-hospital death = 0.30; 
95% CI, 0.08-1.49).
Conclusions: Compliance with recommended guidelines for the management of pts 
with NSTE-ACS results in lower hospital mortality, independently of risk stratiﬁcation 
markers.
9:48 a.m.
811-7 The Impact of Inpatient Quality of Care on 
Socioeconomic Disparities in Outcomes from Acute 
Myocardial Infarction
Susannah M. Bernheim, John A. Spertus, Kimberly J. Reid, Elizabeth H. Bradley, Eric D. 
Peterson, Rani A. Desai, Saif Rathore, Harlan M. Krumholz, Cardiovascular Outcomes 
Research Consortium, Kansas City, MO
Background: While studies have suggested that low socioeconomic status (SES) patients 
fare worse after acute myocardial infarction (AMI), the inﬂuence of differences in the 
quality of medical care that they receive - a potentially modiﬁable factor - is unknown.
Methods: The PREMIER registry prospectively enrolled 2,498 AMI patients from 19 US 
hospitals between 1/1/03 and 6/28/04. Enrolled patients had a detailed chart abstraction 
and interview at the time of hospitalization and follow-up interviews were obtained 6 
months later. SES was quantiﬁed by self-reported household income and education level. 
Quality of care was measured as the percentage of eligible CMS performance measures 
a patient received.
Results: Follow-up rates were 100% for mortality and 87.4% for rehospitalization. 18% 
of our sample had a household income <$10,000 and 22% had less than a high school 
education. Compared with the highest income group (>$70,000; n= 346), patients in the 
lowest stratum of income had signiﬁcantly higher all-cause mortality (9.6% vs. 2.7%, 
p< 0.001) and re-hospitalization (35.6% vs. 26.1%, p< 0.001) at 6 months follow-up. 
Lower income patients also received worse quality care (85% v 91% of eligible quality 
measures, p < 0.001). Results were similar for the lowest education group. Income was a 
stronger predictor of outcomes than education in all multivariable models simultaneously 
containing both income and education. After adjusting for clinical covariates, insurance 
status, and demographics, household income had a strong inverse association with 
mortality. (Hazard ratio <$10K vs. >$70K 3.0 (1.3-6.7)). This association between income 
and mortality was considerably attenuated by the addition of quality of care measures to 
the model. (Hazard ratio 2.1 (0.9 - 4.8)). For re-hospitalization a similar but less dramatic 
decline in hazard ratio was seen (1.3 (1.0 - 1.8) before vs. 1.2 (0.9-1.7) after adjusting for 
the quality of inpatient care).
Conclusion: Patients of lower SES have higher mortality and rehospitalization 6 months 
post-discharge for AMI, and these poorer outcomes are attributable, in part, to worse 
quality of inpatient care.
10:00 a.m.
811-8 Impact of Restrictive Access to Clopidogrel Following 
Coronary Stent Implantation on Patient Health 
Outcomes
Odile Sheehy, Jacques LeLorier, Stéphane Rinfret, Centre Hospitalier de l’université de 
Montréal- Research Center, Montréal, PQ, Canada
Background. Access to clopidogrel is currently restricted in most Canadian provinces. 
To allow reimbursement, the Quebec third party payer needs to review a faxed Special 
Access form. The impact of such a restricted access on outcomes following coronary 
stenting, for which clopidogrel is clearly indicated, is unknown.
9:12 a.m.
811-4 A Routine Intervention Strategy in Patients With Non-ST 
Segment Elevation Acute Coronary Syndromes Is Not 
Superior to a Selective Intervention Strategy: A Meta-
Analysis of Randomized Controlled Trials
Rehan Qayyum, Muhammad R. Khalid, Jurga Adomaityte, Stylianos P. Papadakos, 
Frank C. Messineo, Prudich Medical Center, Montcalm, WV, New York Hospital Queens, 
Flushing, NY
Background: A number of trials have compared a routine intervention strategy (RIS) to 
a selective intervention strategy (SIS) in patients with non-ST segment elevation acute 
coronary syndromes (NSTEACS) with inconsistent results.
Methods: Therefore, we performed a meta-analysis of clinical trials that compared a RIS 
in patients with NSTEACS who underwent cardiac catheterization (cath) to a SIS in which 
patients underwent cath as determined by their clinical course . We identiﬁed randomized 
controlled trials involving patients with NSTEACS who were randomized to either a RIS or 
a SIS through search of PubMed, the Cochrane databases (both from 1970 to September 
2005), and hand search of references from articles. Outcomes of interest were death, 
nonfatal myocardial infarction (MI), and a combined endpoint of death or nonfatal MI. 
Maximum reported follow-up was utilized.
Results: Ten trials met our inclusion criteria (paients = 10648, median follow up = 12 
months, range 6 to 60 months). In the RIS group, 336 patients died as compared to 381 
patients in the SIS group (pooled odds ratio [OR] = 0.87, 95% CI: 0.68, 1.10). There were 
444 nonfatal MI in the RIS group as compared to 520 nonfatal MI in the SIS group (OR 
= 0.84, 95% CI: 0.66, 1.07). Similarly, the composite endpoint of death or nonfatal MI 
showed a statistically insigniﬁcant trend favoring RIS (742 vs. 841; OR = 0.85, 95% CI: 
0.69, 1.06).
Conclusions: When RIS was compared to a SIS in patients with NSTEACS, there was no 
difference in incidence of death and recurrent MI.
 
9:24 a.m.
811-5 What Aspects of Hospital Culture Inﬂuence Quality?
Barbara L. Lytle, Elizabeth S. Fraulo, Brian H. Neelon, Vincent A. Miller, Matthew T. Roe, 
E. Magnus Ohman, W. Brian Gibler, Eric D. Peterson, Duke Clinical Research Institute, 
Durham, NC
Background: Prior research has demonstrated considerable national variation in care, as 
well as a link between healthcare quality and outcomes. Quality also has been associated 
with cultural and process elements, such as physician leadership, administrative support, 
data feedback, and organizational culture. Among a group of hospitals participating in a 
national quality improvement (QI) initiative, we evaluated whether such constructs were 
associated with better performing hospitals.
Methods: From 1/04 to 11/04, we surveyed 284 US hospitals participating in CRUSADE. 
Staff involved in QI speciﬁc to acute coronary syndrome care were interviewed about 
their institution’s QI culture. We evaluated the relationship between markers of quality and 
hospital use of 9 ACC/AHA Class I care indicators among eligible patients. Adherence was 
deﬁned as percentage of guidelines-consistent care out of total care opportunities in 2004.
Results: Leading hospitals (upper quartile) had a median (25th, 75th percentile) 
adherence of 89% (87, 91), compared to 80% (76, 84) for all remaining hospitals. Center 
performance was not distinguished by use of data feedback (88 vs. 90%), consensus on 
QI goals (56 vs. 52%), QI ﬁnancial resources (56 vs. 56%), effective administrative support 
(80 vs. 81%), or greater levels of clinical autonomy (64 vs. 70%, all NS). Leading centers 
were more likely to identify a physician effective in QI efforts (79 vs. 62%, p=0.013).
Conclusions: This study highlights the difﬁculty of characterizing cultural factors that 
promote healthcare quality, particularly using a structured interview. Among hospitals 
participating in a national QI initiative, physician leadership in local QI efforts stood out 
for its ability to differentiate between higher- versus lower-performing centers. Creative 
efforts are needed to identify and discriminate those institutional factors that promote QI 
and, subsequently, better outcomes.
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Methods. We analysed all-cause mortality in the year following coronary stent implantation 
in a large cohort of elderly patients who underwent coronary stent implantation between 
January 2000 and September 2004. We used administrative data from Régie de 
l’assurance maladie du Québec (RAMQ), which reimburses physician fees and drugs. 
The difference in time between ﬁlling any other non-restricted preventive cardiovascular 
drug (PCD) prescription prior to ﬁlling the ﬁrst clopidogrel prescription was assumed to be 
attributable to the restrictive administrative process.
Results. The cohort was composed of 13,663 patients who had not ﬁlled a clopidogrel 
prescription during the year preceding stenting, and who also had ﬁlled a prescription 
for another non-restricted PCD following stent implantation. In the 2745 patients (20.1% 
of the study cohort) who experienced at least one day delay to ﬁll the clopidogrel 
prescription, we observed a signiﬁcant increased risk of all-cause mortality during the 
follow-up period of 365 days (HR=2.03). After controlling for imbalanced co-morbidities 
including age, gender, chronic disease score, healthcare resource utilization in the year 
prior to stenting, at least one day of delay between ﬁrst dispensation of other PCD and 
clopidogrel was still associated with a signiﬁcant increase (HR=1.47 95% CI=1.20-1.80) 
in all-cause mortality. Time-dependent exposure to clopidogrel was extremely protective 
(HR=0.61, 95%CI=0.49-0.77).
Conclusion. Results of this study suggest that restrictive access to clopidogrel in a 
publicly funded healthcare system may increase the risk of all-cause mortality following 
coronary stent implantation.
POSTER SESSION
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968-145 HDL Not Predictive of Longevity or Cardiovascular 
Events in Older Adults: Findings From the EPESE 
Study
Lisa M. Millman, Yun Wang, JoAnne M. Foody, Yale University School of Medicine, New 
Haven, CT
Background: High density lipoprotein cholesterol (HDL-c) is an independent risk factor 
for coronary heart disease & guidelines recommend aggressive management of HDL 
irrespective of age. Despite this, data regarding the clinical utility of HDL-c in older adults 
are scant and conﬂicting. We sought to determine the prognostic signiﬁcance of HDL-c 
below the currently recommended levels (<50 mg/dL in women & <40 mg/dL in men) in 
adults >70 yrs of age.
Methods: We utilized data from the Established Populations for Epidemiologic Studies of 
the Elderly (EPESE). Demographics, lifestyle, & medical history were obtained at baseline 
& follow-up. Serum measures included LDL-c, HDL-c, total cholesterol, triglycerides, 
glucose, BUN & creatinine at baseline. Functional measures of activities of daily living, 
gross mobility, physical performance difﬁculties, & cognitive function were assessed 
annually using standard validated instruments. All-cause mortality was monitored yearly 
using death certiﬁcates. Cause of death was coded using ICD-9-CM codes and further 
classiﬁed as cardiovascular (acute myocardial infarction, AMI; coronary artery disease, 
CAD; congestive heart failure, CHF). Cox proportional hazards models were developed to 
assess the association between low HDL-c (<50 mg/dL in women & <40 mg/dL in men) 
with 5-yr cardiovascular & all-cause mortality.
Results: Low HDL-c was not signiﬁcantly associated with crude all-cause, AMI, CHF, 
& stroke mortality. HDL-c was signiﬁcantly associated with unadjusted CAD (P= .033) 
mortality. However, after adjustment for demographic, clinical, & functional covariates, 
HDL-c was not associated with 5-yr all-cause, AMI, CAD, CHF or stroke mortality (HR = 
1.03, 95% CI 0.90-1.18), (HR=1.09, 95% CI 0.70-1.71), (HR=1.33, 95% CI 0.91-1.92), 
(HR=1.07, 95% CI 0.63-1.81) & (HR=0.80, 95% CI 0.51-1.27) respectively.
Conclusions: In older community dwelling adults enrolled in the EPESE study, low 
HDL-c levels were not associated with increased risk of 5-yr cardiovascular, stroke or all-
cause mortality. HDL-c alone may have minimal incremental effects on future longevity or 
cardiovascular events in older adults due to competing risk & co-morbid conditions.
968-146 Patient Knowledge and Statin Use
Thomas M. Maddox, Kimberly J. Reid, P. Michael Ho, Harlan M. Krumholtz, William S. 
Weintraub, John S. Rumsfeld, John A. Spertus, Cardiovascular Outcomes Research 
Consortium, Kansas City, MO
Background: Statins are a cornerstone of post-MI therapy, and yet, rates of statin use 
decline signiﬁcantly after hospital discharge. Patients’ uncertainty about the goals of statin 
therapy may contribute to this decline. We evaluated the association between patient 
knowledge of target cholesterol levels 1 month after MI discharge, 6-month statin use, 
and 12-month mortality.
Methods: We assessed patient knowledge of their target cholesterol levels 1 month 
after MI hospitalization in patients enrolled in the 19-center PREMIER registry. We 
then compared 6 month statin use and 12-month mortality rates between patients 
with and without knowledge of cholesterol targets. Multivariable models were used to 
adjust for potential confounders, including age, sex, race, educational level, history of 
hyperlipidemia, history of dementia or depression, patients’ belief in their ability to affect 
their own health, patients’ tendency to avoid health care due to cost, and whether or not 
patients received inpatient cardiac rehabilitation.
Results: Among 1671 patients who received statins at hospital discharge, 569 (34.1%) 
knew their target cholesterol goals 1 month later. Patients with such knowledge were 
younger, and more likely to be white, high school graduates, medically insured, and to 
have received inpatient cardiac rehabilitation. Patients without knowledge had higher 
rates of depression and were more likely to avoid health care due to its cost. Knowledge of 
target cholesterol levels was associated with statin use at 6 months (81.8% vs. 71.3%; p-
value <0.001) and lower 12-month mortality (unadjusted hazard ratio 0.3, 95% C.I. (0.16, 
0.55), p-value <0.0001). After multivariable adjustment, patient knowledge remained 
signiﬁcantly associated with 12 month mortality (adjusted hazard ratio 0.42; 95% C.I. 
(0.22, 0.8), p-value 0.008).
Conclusions: Patient knowledge of target cholesterol levels 1 month after MI is associated 
with 6-month statin use rates and 12-month mortality. This supports the potential 
importance of patient education with regard to medication adherence and outcomes, 
although further research to understand what speciﬁc factors mediate this association 
is warranted.
968-147 Performance Characteristics of Stress Testing in 
Contemporary Practice: Long-term Prognosis
James G. Jollis, Salvador Borges-Neto, Duke University, Durham, NC
Background: As payers are challenged by a doubling in the number of imaging studies 
over the next 6 years, they increasingly require evidence of their value. The ability to 
separate groups according to prognosis represents an important performance measure 
of stress imaging, allowing for the application of expensive therapies to those patients 
most likely to beneﬁt.
Methods: We examined the survival of 9,725 patients [median age 60, female 37%, 
black 18%, hypertension 67%, diabetes 30%] who underwent stress testing and coronary 
angiography between 1996 and 2004 followed in the Duke Cardiovascular Disease 
Databank for up to 9 years [mean 3.9 years].
Results: Kaplan-Meier curves below show survival according to stress test results and 
the presence or abscence of coronary disease (>70% stenosis). Patients with a positive 
stress test and coronary disease had signiﬁcantly worse prognoses. Of potentially greater 
interest, patients with coronary disease who also had a negative stress test had survival 
that was not signiﬁcantly different than patients without coronary disease. Stress ECG 
alone was unable to identify this low risk coronary disease cohort.
Conclusions: These data involving stress imaging in a large contemporary series of 
patients with long-term follow up demonstrate that association with prognosis is potentially 
more important than correlation with angiography. Patients with negative stress imaging 
studies have an excellent prognosis regardless of the results of coronary angiography. 
968-148 Using Telemedicine to Decrease Cardiovascular Risk in 
Underserved Populations
William P. Santamore, Carol Homko, Abul Kashem, Robert C. Cross, Hammad A. 
Aziz, Timothy R. McConnell, Francis J. Menapace, Alfred A. Bove, Temple University, 
Philadelphia, PA
Background: In underserved populations, inadequate surveillance and treatment 
allows glucose intolerance, hyperlipidemia, and hypertension to persist until actual 
cardiovascular events occur. Thus, we developed an Internet-based Telemedicine 
System to address the high prevalence and suboptimal control of cardiovascular disease 
(CVD) risk factors in this population. We hypothesize that a Telemedicine system would 
by frequent communication with health care providers, self-monitoring, and education 
signiﬁcantly decrease CVD risk.
Methods: Inner city and rural subjects (24% African-American or Hispanic) with 10% or 
greater CVD risk (Framingham 10 year risk score) and with treatable risk factors were 
randomized to controls (C) or telemedicine (T). Each subject received a home manometer 
and a pedometer (steps/day). The telemedicine group transmitted blood pressure (BP), 
weight, and step data, and in return received feedback and educational information.
Results: Baseline values were similar between groups (T: N= 63 , mean age 64.5+7.9 yrs, 
systolic / diastolic BP 149.6+18.7 / 81.1+10.5 mmHg, cholesterol 195.4+42.5 mg/dl, and 
C: N=54, mean age 63.8+10.0 yrs, systolic / diastolic BP 147.4+20.4 / 79.0+11.4 mmHg, 
cholesterol 209.0+43.5 mg/dl). The initial mean 10-year CVD risk was 17.6+9.9% in T and 
17.3+10.2% in C. At 8-months, T patients had achieved signiﬁcant reductions (p<0.05) 
in systolic and diastolic BP (-16.4+17.8 / -5.4+10.1 mmHg), BMI (-0.4+3.1 kg/m2), waist 
circumference (-1.29 +9.1 in), fasting blood glucose (12.8+45.9 mg/dl), total cholesterol (-
11.4+33.4 mg/dl) and overall CVD risk (-1.6+5.7%) while C patients achieved a signiﬁcant 
reduction in systolic BP only (-7.2+19.8 mmHg)
Conclusions: An Internet-based Telemedicine (T) system can help to reduce CVD risk 
in underserved populations.
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968-149 Should Warfarin Be Monitored by Anticoagulation 
Clinics or by Physician Practices?
Greg C. Flaker, Samuel Z. Goldhaber, Christopher Granger, Inder Anand, Alan 
Jacobson, Robert Black, Stuart Connolly, Salim Yusuf, Marc Pfeffer, University of 
Missouri, Columbia, Columbia, MO, Brigham and Women’s Hospital, Boston, MA
Background: The optimal method of maintaining therapeutic warfarin, either by 
anticoagulation clinic or by ofﬁce practice, remains uncertain.
Methods: A survey sent to ACTIVE centers in the United States disclosed that 38 sites 
monitor INR values by an anticoagulation clinic and 30 sites use physician ofﬁces.
Results: Globally, 6,658 patients have been randomized to either warfarin or clopidogrel 
plus aspirin with 64% of INR values between 2-3 in warfarin treated patients. Data from 
the 68 centers in the United States that completed the survey are shown in the Table. 
Anticoagulation Clinic
N=38
Private Practice
N=30 P value
N 255 162
Male 163 (64%) 110 (68%) 0.40
Age (yrs) 73.1 ± 9.5 71.5 ± 11.1 0.12
Hx of Stroke/TIA 20 (7.8%) 10 (6.2%) 0.52
Hypertension 207 (81.2%) 135 (83.3%) 0.58
CAD 91 (35.7%) 63 (38.9%) 0.51
CHF 56 (22%) 47 (29%) 0.10
Diabetes 58 (22.8%) 45 (27.8%) 0.25
# INR’s 2,927 1,884
% INR 2-3 1,929 (65.9%) 1,193 (63.3%) 0.07
%INR 1.8-3.2 2,349 (80.3%) 1,470 (78%) 0.06
Conclusions: 1) In ACTIVE, anticoagulation quality, as measured by the % of INR’s 
in the 2-3 range is comparable to previous randomized trials. 2) In the United States, 
patients followed in anticoagulation clinics appear to be at similar clinical risk for stroke 
compared to patients followed in ofﬁce practice. 3) In this trial INR control was good 
in both groups but tended to be better in anticoagulation clinics than ofﬁce practices. 
Whether these differences translate into reduced strokes or bleeding events remains to 
be determined.
968-150 Performance Characteristics of Stress Testing in 
Contemporary Practice: Comparison to Angiography
Salvador Borges-Neto, James G. Jollis, Duke University, Durham, NC
Background: Much data regarding stress testing involves carefully selected cohorts, 
older technologies, and methodologies designed to favor a particular technique.
Methods: We took advantage of prospective data collection in the Duke Cardiovascular 
Disease Databank to compare the performance characteristics of stress ECG, stress echo, 
and stress nuclear perfusion testing in routine contemporary use. 9,725 patients [median 
age 60, female 37%, black 18%, hypertension 67%, diabetes 30%, median time to cath 
4 days] from 1996 to 2004 who underwent stress testing prior to coronary angiography 
were compared according to the identiﬁcation of coronary disease (>70% stenosis) and 
severe disease (3 vessel or left main stenoses). All patients had an adequate ECG stress 
according to heart rate and interpretable tracings.
Results: All three tests had performance characteristics that were somewhat lower 
than those commonly quoted in the literature. Part of the difference in performance 
may be accounted for by the bias involved in selection for angiography (underestimate 
of speciﬁcity and overestimate of sensitivity). Combining ECG and imaging data further 
improved overall performance.
Conclusions: These data demonstrate that cardiac imaging in routine use adds 
substantial diagnostic information to stress ECG. The ﬁndings also provide contemporary 
benchmarks by which the quality of stress testing can be measured.
Sensitivity Speciﬁcity Sensitivity3V / LM CAD
Speciﬁcity
3V / LM CAD
stress ECG 50% 68% 65% 64%
stress echo 79% 32% 88% 29%
stress nuclear 80% 34% 89% 28%
 
968-151 LDL Control in Patients Undergoing Peripheral Arterial 
Revascularization Procedures Compared to Coronary 
Arterial Revascularization Procedures
Sean P. Javaheri, Eric A. Shry, Michael C. Casciello, Jill Feig, Bernard J. Rubal, Alan 
Sim, Brooke Army Medical Center, San Antonio, TX, Brooks Air Force Base, San 
Antonio, TX
Background: Atherosclerotic peripheral arterial disease (PAD) is a coronary heart 
disease (CAD) risk equivalent. Current guidelines recommend a goal LDL-C <100mg/dl. 
There is little data on LDL control in patients with PAD.
Methods: We performed a retrospective evaluation of all patients undergoing PAD 
and CAD revascularization procedures (using ICD-9 codes) in the military health care 
system from January, 2000 to September, 2004. PAD patients with known CAD were 
excluded from analysis. We then assessed LDL measurement and control at the time of 
revascularization and at 6 months after the procedure, accessing all laboratory testing 
performed at military facilities during the study period. LDL measurement and degree 
of control was compared between patients undergoing PAD revascularization and CAD 
revascularization.
Results: There were 1957 and 9389 patients in the PAD and CAD revascularization 
groups, respectively. Of these, 958 (49%) patients in the PAD group and 9218 (98%) 
patients in the CAD group underwent any assessment of cholesterol within 1 year of 
the revascularization procedure. Of the 303 and 4813 patients in the PAD and CAD 
revascularization groups with both baseline and follow-up LDL levels, 44% in both groups 
had LDL-C levels of less than 100 mg/dl at the time of revascularization (p=NS). The 
mean LDL-C in patients undergoing PAD revascularization was 111 mg/dl ±37 mg/dl at 
baseline, and at follow up was 116 mg/dl±33mg/dl (p=0.12). The mean LDL-C in patients 
undergoing CAD revascularization was 110 mg/dl ±38 mg/dl at baseline, and at follow 
up was 93 mg/dl± 30 mg/dl (p<0.0001). At 6 months, the proportion in the PAD group 
and CAD group with LDL-C < 100 mg/dl had increased to 47.5% (Δ15.8%) and 66.4% 
(Δ26.9%, p<0.001).
Conclusions: Signiﬁcantly fewer patients undergoing PAD revascularization procedures 
have their lipids assessed. When assessed, LDL-C is poorly controlled in PAD 
revascularization patients when compared to CAD patients undergoing revascularization. 
Following PAD revascularization procedures, most patients do not meet NCEP ATP III 
guidelines for LDL control, and are less likely to achieve LDL goals than patients following 
CAD revascularization.
968-152 Specialized Lipid Clinic Management of Hyperlipidemia 
in Patients With Coronary Artery Disease: How Long 
Does the Effect Last?
Mouaz Al-Mallah, Mohamad Sinno, Ajay Srivastava, Sanjaya Khanal, Henry Ford Heart 
and Vascular Institute, Detroit, MI
Background: We have previously demonstrated that management of patients with 
coronary artery disease (CAD) in specialized lipid clinics(LC) may achieve better lipid 
results. It is not clear whether this favorable effects endure after completion of the study.
Methods: Patients presenting to a single cardiac catheterization laboratory, who were 
found to have angiographic CAD were randomized to follow up with LC or Standard care 
(SC) for two years. Patients were followed up for one year after the termination of the trial 
to assess for durability of achievment of lipid target. Comparisons were conducted using 
Students t-test.
Results: Of 1233 patients who were enrolled, 617 were randomized to the LC arm and 
616 to the SC arm. Mean age was 63±11 years and 38% were females. There were 
no differences in the baseline characteristics between the two groups. Low Density 
lipoprotein (LDL) and high density lipoprotein (HDL) cholesterol and triglycerides (TG) 
at baseline and at the end of the study are shown below. 921 patients had followup lipid 
proﬁle within 1 year of terminating the study. LC patients had no change in their lipid 
proﬁle while patients in the SC group had mostly caught-up with patients managed in the 
LC (LDL and TG were equal with marginal difference in HDL).
Conclusion: Patients in LC achieved better target lipid proﬁles compared to SC during 
the active study. The lipid effect is sustained after discharge from the LC. However, SC 
patients catch up in their lipid proﬁles within one year of study discontinuation.
Lipid Proﬁles Before, During and After Study Between LC and SC
Variable Lipid Clinic N=617 Standard Care N=617 p value
Baseline LDL mg/dl 107 ± 37 103 ± 37 0.7
Baseline HDL
mg/dl 44 ± 13 43 ± 12 0.4
Baseline TG mg/dl 153 ± 124 161 ± 181 0.3
Study-end LDL
mg/dl 85 ± 30 93 ± 31 0.04
Study-end HDL
mg/dl 50 ± 14 50 ± 13 0.7
Study-end TG mg/dl 146 ± 82 160 ± 89 0.04
Post-study LDL mg/dl 85 ± 32 85 ± 33 0.9
Post-study HDL mg/dl 53 ± 16 51 ±15 0.04
Post-study TG mg/dl 144 ± 92 150 ± 95 0.4
 
968-153 Pregnancy Complications as Risk Factors for Cardiac-
and All-Cause Mortality
Mimi S. Biswas, Monique Chireau, Emily Honeycutt, Haywood Brown, L Kristin Newby, 
Lori A. Bastian, Duke University Medical Center, Durham, NC, Durham Veterans 
Administration Medical Center, Durham, NC
Background: Adverse pregnancy outcomes have been associated with poor maternal 
cardiovascular outcomes in population studies, but their risk for cardiac and all-cause 
mortality has not been studied.
Methods: We performed a retrospective cohort study merging data from the Duke 
University Perinatal and Health Services Outcomes Database (PHSOD) , the Duke 
Information System for Cardiovascular Care (DISCC), and the National Death Index. The 
42,263 patients in the PHSOD were queried in the DISCC database, yielding 415 patients. 
Cox proportional hazards modeled predictors of cardiac death and all-cause mortality, 
using accepted cardiac risk factors as well as pregnancy complications, including ICD-
9 codes for abruption, preeclampsia, preterm birth, gestational diabetes, in-utero fetal 
demise, small- and large-for gestational age, oligohydraminos, post-partum hemorrhage, 
stillbirth, and twins.
Results: Median age at delivery was 28 years [23, 33 IQR] and 41 years at catheterization 
[35, 47 IQR]. Median age at ﬁrst myocardial infarction was 43 years [37, 48 IQR]. Median 
age at death was 42 years [36, 49 IQR]. Women with pregnancy complications (n=214) 
were more likely diabetic, with hypertension, unstable angina, and CAD by catheterization 
(35% vs. 24% p 0.02). In univariate analysis, factors associated with cardiac mortality 
were Caucasian race, diabetes, congestive heart failure, gestational diabetes, and any 
adverse pregnancy outcome, while factors associated with all-cause mortality were the 
above, plus current smoking and body mass index, but not race. Multivariate analysis 
associated congestive heart failure (HR 1.9 [1.0-3.7]) and any pregnancy adverse 
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outcome (HR 2.4 [1.2-4.9]) with cardiac mortality, while congestive heart failure (HR 1.2 
[1.0-1.5]), current smoking (HR 2.0 [1.1-3.5]) and gestational diabetes (HR 2.5 [1.4-4.4]) 
were associated with all-cause mortality.
Conclusions: In this young cohort, history of pregnancy complications is associated 
with signiﬁcant risk for all cause mortality and cardiac death. Women identiﬁed as having 
increased mortality risk based on pregnancy complications may beneﬁt from early 
preventive interventions.
968-154 Meta-Analysis of the Association of Anemia, Chronic 
Kidney Disease (CKD), and Cardiovascular Disease 
(CVD)
Wayne Levy, Enkhe Badamgarav, Reshma Kewalramani, Paul Song, Irene Agodoa, 
Jessica Nora, Robert Dubois, Norman Lepor, Cerner Health Insights, Beverly Hills, CA
Background: Based on an American Heart Association Scientiﬁc Statement, CKD is 
a risk factor for CVD. Increased CVD risk is attributable to several factors, and recent 
studies suggest anemia is an important moderator of CVD risk in CKD patients. To 
determine the overall magnitude, we performed a meta-analysis of CVD risk in CKD 
patients not on dialysis and examined the role of anemia as a risk modiﬁer in this cardio-
renal association.
Methods: We systematically reviewed MEDLINE and COCHRANE databases for 
English-language articles published between January 1980 and July 2005. We identiﬁed 
3002 articles using keywords and MeSH terms related to anemia, renal failure, CKD, 
and CVD. We included only large-scale prospective cohort studies that examined the 
incidence of CVD events in CKD patients not on dialysis.
Results: We identiﬁed 11 prospective community-based studies evaluating 2,069,253 
patients (follow-up duration: 3-18 years). Studies differed on CKD deﬁnition, outcomes 
assessed, and follow-up duration. Pooled estimates were grouped by outcome. Meta-
analysis showed that CKD patients had a signiﬁcantly higher incidence of CVD events 
compared to non-CKD patients: CHF, HR=1.4 (95% CI=1.17-1.62); CVD, HR=1.4 
(95% CI=1.01-1.86); stroke, HR=1.8 (95% CI=1.42-2.31). Similarly, CKD patients had 
a signiﬁcantly higher incidence of CVD mortality (HR=1.6, 95% CI=1.56-1.73) and all-
cause mortality (HR=1.4, 95% CI=1.28-1.45). Anemia was associated with a signiﬁcantly 
higher risk of stroke (HR=5.4, 95% CI=2.04-14.43) and CHD (HR=2.7, 95% CI=1.42-
5.28), with a trend towards an increase in CVD mortality (HR=1.3, 95% CI=0.83-1.98) 
in patients with CKD.
Conclusions: This is the ﬁrst study to quantify the magnitude of CVD events in CKD 
patients not on dialysis. Pooled estimates showed that CKD patients are at increased risk 
of CVD-related morbidity and mortality compared to patients without CKD. Anemia seems 
to increase CVD risk in CKD patients, but these ﬁndings were based on limited evidence. 
Ongoing randomized trials, such as TREAT (The Trial to Reduce Cardiovascular Events 
with Aranesp Therapy) will provide insights into anemia treatment and mitigation of CVD 
risk in CKD patients.
968-155 The Cost-Effectiveness of Perindopril in Reducing 
Cardiovascular Events in Patients With Stable Coronary 
Artery Disease Using Data From the EUROPA Study
Andrew Briggs, Borislava Mihaylova, Mark Sculpher, Alistair Hall, Jane Wolstenholme, 
Maarten Simoons, Roberto Ferrari, Willem J. Remme, Michel Bertrand, Kim Fox, 
University of Glasgow, Glasgow, United Kingdom
Background: The EUropean trial on Reduction Of cardiac events with Perindopril in 
stable coronary Artery disease (EUROPA) trial has recently reported. The aim of this 
study is to assess the cost-effectiveness of perindopril in stable coronary heart disease in 
the UK, based on data taken from this trial.
Methods: Clinical and resource use data were taken from the EUROPA trial. Costs 
included all medications and hospitalisations. Health-related quality of life values were 
not collected inthe trial and these were therfore taken from published sources. Cost-
effectiveness analysis is presented as a function of the risk of a primary event (non-
fatal myocardial infarction, cardiac arrest or cardiovascular death) in order to identify 
individuals for whom treatment offers greatest value for money.
Results: The median incremental cost per QALY gained of perindopril across the 
heterogeneous population of EUROPA was estimated as £9,500 (inter-quartile range: 
£6,500-£14,400). Overall, 89% of the EUROPA population had a point estimate of 
incremental cost per QALY below £20,000 and 97% below £30,000. For a threshold value 
of cost-effectiveness of £30,000 per QALY gained, individuals representing the 25th, 50th 
(median) and 75th percentiles of the cost-effectiveness distribution for perindopril have 
probabilities of 0.99, 0.98 and 0.92 of being cost-effective, respectively. Cost-effectiveness 
was strongly related to higher risk of a primary event under standard care.
Conclusions: Whether the use of perindopril can be considered cost-effective 
depends on the health care systems’ threshold values of cost-effectiveness. For the 
large majority of patients included in EUROPA, the incremental cost per QALY gained 
is lower than the apparent threshold used by the National Institute for Health and 
Clinical Excellence in the UK.
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990-145 Improving Compliance With Heart Failure Core 
Measures: Michigan Heart Failure Discharge Document 
Initiative
Syed M. Jafri, Arthur L. Riba, Cecelia K. Montoye, Theresa A. Aldini, Alice Betz, Linda J. 
Charles, Anthony C. DeFranco, Todd M. Koelling, David Share, Stuart A. Winston, Eric 
R. Bates, Henry Ford Healthcare System, Detroit, MI, Oakwood Healthcare System, 
Dearborn, MI
Background: The quality mission of the American College of Cardiology (ACC) is to 
encourage state chapters to lead quality improvement (QI) projects and engage ACC 
members as quality champtions, but the means to accomplish this is uncertain. The goal 
of this project was to develop a collaborative QI initiative coordinated by the Michigan 
Chapter of the ACC (MACC) to improve heart failure (HF) discharge peformance.
Methods: A partnership between the MACC, MPRO, Blue Cross/Blue Shield of Michigan, 
and the Greater Flint Health Coalition was established. All Michigan hospitals submitting 
performance data to the QNet Exchange were invited to participate. Project leads and 
Physician Champions participated in an introductory Web-ex teleconference. Project 
leaders attended two learning and sharing sessions on: project planning; developing, 
implementing, and monitoring use of a standard discharge document (DD) embedded 
with key HF care standards; QI strategies; and overcoming barriers. Project teams were 
then expected to apply HF care standards and process improvements; optimize use of 
DD; and monitor tool use. Compliance rates with the standard six core measures were 
compared for participating hospitals (MHFDDI) vs. non-participating hosptials (CTLS) 
before and after the intervention period.
Results: Thirty-nine hospitals (27 urban, 12 rural) particiapted. Attendance at learning 
sessions was 100%. Documentation of all six HF core measures was similar at baseline 
(Oct-Dec,2003) for MHFDDI and CTLS: 50 vs. 48%, p=NS. During remeasurement (Oct-
Dec, 2004), compliance was signiﬁcantly higher in MHFDDI: 68 vs. 55%, p<0.01. The 
impact of the project on readmission rates is being analyzed.
Conclusions: An ACC State Chapter can lead a QI initiative, develop a successful 
high proﬁle partnership, and engage ACC members in QI efforts. As a result of this 
collaborative, HF discharge care improved by use of a standard discharge document, 
and hospital teams embraced a rapid cycle collaborative model of QI.. The lessons 
learned are being applied to a second project focusing on the use of a comprehensive 
cardiovascular DD.
990-146 Evaluation of the Patient Global Assessment 
Questionnaire as a Health Status Measure for Heart 
Failure
Charles W. Tate, III, Alastair D. Robertson, Michael R. Bristow, Brian D. Lowes, 
University of Colorado, Denver, CO
Background: The Beta-blocker Evaluation of Survival Trial (BEST) utilized a patient global 
health response questionnaire (Patient Global Assessment, PTGA) that to our knowledge 
has not been formally validated. The aim of this study was to determine the relationship 
between the PTGA and modiﬁed San Diego Heart Failure (SDHF) Questionnaires 
to the previously extensively validated Minnesota Living with Heart Failure (MLHF) 
Questionnaire, as well as to assess the abilities of these quality of life instruments to 
predict clinical outcomes in patients with advanced heart failure (HF) in BEST.
Methods: All three instruments were administered at 0, 3, 6, 12…48 months. PTGA 
measured change since baseline. SDHF and MLHF measured current status, and changes 
from baseline were calculated. For each instrument, a low value for change indicates 
improvement in quality of life. For the three instruments, Spearman correlation was used to 
assess interrelationships and Cox proportional hazards regression was used to assess the 
prediction of time to all cause mortality and the composite endpoints of all cause mortality 
plus all cause hospitalization, and all cause mortality plus HF hospitalization, bivariately and 
multivariately. Transplant subjects were censored at time of transplant.
Results: At 12 months, PTGA (r=0.37) and SDHF (r=0.56) correlated with MLHF, p=0.0001 
for both. SDHF (p=0.0001), MLHF (p=0.001) and PTGA (p=0.0001) were strongly 
associated with all cause mortality, with low values of each associated with a lower hazard. 
For subsequent all cause mortality and HF hospitalization, respective p values were: 
0.0008, 0.0040 and 0.0001. For subsequent all cause mortality and all cause hospitalization, 
respective p values were: 0.0006, 0.0021 and 0.0001. For each of the three endpoints, 
multivariate analysis showed that PTGA predicted independently and highly signiﬁcantly 
(p=0.0001), while controlling for SDHF and MLHF, which were non signiﬁcant.
Conclusion: Each of the three instruments was associated with all cause mortality, 
all cause hospitalization, and HF Hospitalization. In multivariate analysis, PTGA was a 
stronger predictor of clinical endpoints than SDHF or MLHF.
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990-147 The Safe Use of Aldosterone Antagonists in Patients 
With Chronic Heart Failure and Associated Chronic 
Kidney Disease Facilitated by a Protocol in an 
Outpatient Clinic
Michael A. Hanna, Veronica Sumodi, Karen Fagnilli, Hillcrest Hospital Cleveland Clinic 
Health System Eastern Region, Mayﬁeld Hts, OH
Background: Aldosterone antagagonists are important drugs in the management of 
chronic heart failure and post-infarction left ventricular failure by reducing mortality and 
sudden death. Chronic kidney disease (CKD) is a major risk factor for the development 
of hyperkalemia. CKD is deﬁned as estimated glomerular ﬁltration rate (GFR) <60 using 
the Cockroft-Gault formula.
Methods: The population is a convenience sample of systolic heart failure patients in an 
outpatient center with New York Heart Assosiation Class III or IV (N=65), mean active 
time in clinic is 16 months (longest 6 years, shortest 1 month), 53 had estGFR<60 (mean 
35). A protocol was initiated: instruction on low potassium diet, avoidance of hypovolemia, 
adjustment of dose to estGFR, avoidance of concommitant use of drugs that increase 
potassium (i.e. trimethoprim-sulfamethoxazole and nonsteroidal anti-inﬂammatory drugs), 
monitoring serum potassium levels.
Results: 29 patients (54.7%) were initiated and/or managed on an aldosterone antagonist. 
Mean age of this subset is 75 years, 15 male, 14 female, 9-Stage IV CKD (estGFR 15-29), 
12-Stage IIIb (estGFR 30-44), 8-Stage IIIa (est GFR 45-60). Mean potassium level at start of 
program was 4.3 meq/L. 26 of the 29 were on ACE inhibitors or angiotensin receptor blockers. 
During treatment there was a mean increase in serum potassium of 0.6meq/L. Dose range 
was 12.5 mg every other day to 50mg daily (mean dose-23.7mg daily). There were 3 (10.3%) 
instances of moderate hyperkalemia between 5.5 meq/L and 6.0 meq/L (2 were stage IV 
CKD, 1 was Stage IIIb). An assessment of volume status was made, diuretics adjusted, and 
diet instruction was reinforced. The drug was held temporarily, but not discontinued.. There 
was one incidence (3.4%) of serum level above 6.0 meq/L (6.8meq/L, Stage IV CKD). Patient 
was treated without need for hospitalization and the drug discontinued. Two patients were 
discontiunued due to worsening CKD and physician preference. There were no incidences of 
mortality or hospitalization related to hyperkalemia.
Conclusions: Aldosterone antagonists can be used in the setting of heart failure with 
CKD with a protocol that calls for continuous monitoring in an outpatient setting.
990-148 Relationship Between White Cell Count, Blood Sugar 
Level and Mortality in Acute Coronary Syndromes. The 
Global Registry of Acute Coronary Events
Onn Akbar Ali, Enrique P. Gurﬁnkel, Joel M. Gore, Keith A. Fox, Andrzej Budaj, Giancarlo 
Agnelli, Frederick A. Anderson, Rebecca Dedrick, David Brieger, GRACE Investigators, 
Concord Hospital, Sydney, Australia, UMASS Medical School, Worcester, MA
Background Elevations of white cell count (WCC) and random blood sugar level (BSL) 
are associated with increased hospital mortality in acute coronary syndromes (ACS). 
Systemic inﬂammation and hyperglycemia are associated with enhanced activation of 
platelets and coagulation. We postulated that random BSL would be closely related to 
WCC and that elevations in both would provide similar prognostic information.
Methods The association between admission WCC and random BSL was examined in 
16,513 ACS patients in GRACE. Patients with BSL<70 mg/dL were excluded. Outcomes 
were stratiﬁed according to BSL and WCC. The impact of BSL on outcome was adjusted 
using the GRACE risk score and corrected for WCC.
Results There was a graded association between admission BSL and WCC (BSL<100 
mg/dL, WCC 8.0 (6.5-9.9); BSL 100.1-109.9, WCC 8.6 (6.8-10.6); BSL 110-140, WCC 
9.1 (7.3-11.4); BSL >140, WCC 9.9 (7.8-12.6). Mortality increased with increasing WCC; 
the relation with increasing BSL was less clear due to higher mortality in patients with 
BSL <100 (Fig). Patients with BSL >140 had the highest mortality, which persisted after 
adjustment using the GRACE risk score (OR 1.65, 95% CI 1.27-2.15) and following 
correction for WCC (1.35, 1.03-1.77).
Conclusion There was a graded association between WCC and random BSL. Adjusted 
hospital mortality is increased in patients with BSL >140, even after correction for WCC, 
suggesting that hyperglycemia and systemic inﬂammation independently contribute to a 
fatal outcome in ACS. 
990-149 Prospective, Randomized Controlled Trial Comparing 
the Effectiveness and Safety of a Vascular Closure 
Device and a Topically Applied Hemostatic System 
With Manual Compression in Patients Undergoing 
Cardiac Catheterization and Percutaneous Coronary 
Intervention
Ghadi G. Ghorayeb, Kesevan Prakash, Jeanne Gugudis, Genevieve Valencia, Patricia 
DeCamillo, Anant Dixit, Steven Schwartz, Arthur L. Riba, Oakwood Hospital and Medical 
Center, Dearborn, MI
Background: Vascular site access complications are relatively common after invasive 
cardiac procedures, and lead to increased morbidity, hospitalization and cost. Vascular 
closure devices (VCD) have been incorporated into practice with the expectation of 
reducing times to hemostasis and ambulation; decreasing hospital length of stay; and 
improving patient satisfaction. Recent meta-analyses suggest that VCD might actually 
increase the risk of vascular complications. The purpose of the study was to compare 
the efﬁcacy, safety and impact on operational outcomes of a standard vascular closure 
device (Angioseal®), a topically applied hemostatic system (Stasyspatch®), and manual 
compression (MC).
Methods: Using a prospective, randomized controlled research design, patients (pts) 
undergoing elective cardiac catheterization/ percutaneous coronary intervention (PCI) 
and meeting eligibility criteria were recruited. Pts were randomized to Angioseal® vs. 
Stasyspatch® vs. MC on a 1:1:1 basis with secondary randomization in each group to 
a set time to ambulation. Demographics, past history, medications, procedural and post 
procedural variables, vascular complications, time to discharge and 30-day pt satisfaction 
and outcomes were prospectively collected. Standard statistical analysis was applied for 
comparisons between the three methods of vascular site closure.
Results: During the period of Sept 2004- Aug 2005, 403 patients were randomized. The 
groups were matched for demographics, past medical and cardiac history, interventions 
and medications. There was no signiﬁcant difference in the number or severity of vascular 
complications (14.5% for Angioseal®; 14.7% for Stasyspatch®; and 13.5% for MC, 
p=NS), time to discharge or patient satisfaction. There was no demonstrable advantage 
of using a vascular closure device or hemostatic patch over standard MC.
Conclusion: Based on the results of this study, converting to a strategy of predominantly 
MC for vascular site management after cardiac catheterization/PCI will result in signiﬁcant 
cost savings, with no compromise of pt safety or satisfaction, efﬁcacy or operational 
throughput.
990-150 Increasing Occurrence of Multivessel Intervention and 
Multiple Stent Placement From 1999 to 2004. The Global 
Registry of Acute Coronary Events
Naomi Botkin, Frederick A. Spencer, Robert J. Goldberg, Mark Furman, Gilles 
Montalescot, David Brieger, Shauna Malone, Joel M. Gore, GRACE Investigators, 
UMASS Medical School, Worcester, MA, Centre Hospitalier Universitaire Pitié-
Salpêtrière, Paris, France
Objective: To describe the degree to which multivessel intervention (MVI) and multiple 
stent placement occur in acute coronary syndromes (ACS) using data from the Global 
Registry of Acute Coronary Events (GRACE).
Methods: Data were analyzed from 9,998 patients who presented with unstable angina 
or myocardial infarction from April 1999 to Dec 2004 and underwent percutaneous 
coronary intervention (PCI) during the index hospitalization. Patients were enrolled at 86 
hospitals in 14 countries.
Results: The average number of vessels dilated was 1.2 per patient and the average 
number of stents placed was 1.4. The percentage of patients undergoing MVI increased 
signiﬁcantly in the USA between 1999 (15%) and 2004 (31%), and was greater in the US 
than in other countries in the later years. The percentage of patients undergoing multiple 
stent placement increased signiﬁcantly in the US (from 29% to 39%) and in other countries 
(from 24% to 29%) over the study, and was signiﬁcantly greater in the US than in other 
countries. The following variables were independent predictors of MVI and/or multiple stent 
placement: older age, history of congestive heart failure, no history of CABG, no new ST 
elevation or left bundle branch block, treatment in the US, higher number of vessels with 
signiﬁcant stenosis, later study year, and elective or urgent (not primary) PCI.
Conclusions: These data show that use of MVI and multiple stent placement have 
increased over time and are performed more frequently in the US than in other countries. 
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990-151 A Comparison of Quality of Life Scores in Patients 
With Stable Angina Pectoris After Medical Treatment 
Compared With Angioplasty or Coronary Bypass 
Surgery: 48-Months of Follow-Up Outcomes of a 
Randomized Clinical Trial (MASS I I)
Myrthes E. Takiuti, Celia R. Nogueira, Pryscila Girardi, Teryo Nakano, Jurema Palomo, 
Neuza Lopes, Whady Hueb, José AF Ramires, Heart Institute(InCor), São Paulo, Brazil
Background: Although medical treatment (MT), coronary angioplasty (PCI) and coronary 
bypass surgery (CABG) are traditionally performed, the need to assess the patients’ quality 
of life (QoL) has been regarded with increasing importance. Although QoL instruments 
have been used to assess the efﬁcacy of a therapeutic intervention, they have not been 
used previously to compare the impact of medical treatment with that of PCI or CABG in 
patients with stable angina. This study sought to compare QoL scores during 48 months 
in patients with stable angina and preserved ventricular function submitted to one of these 
treatments: MT, PCI or CABG.
Methods: A total of 611 patients were randomly assigned to either a CABG (n = 203), PCI (n 
= 205), or MT (n = 203) group. The Short Form Health-Related QoL Questionnaire (SF-36) 
was used to assess the quality of life of the patients. Before randomization and at 12, 24, 36, 
and at 48 months, patients completed the questionnaire. We compared the QoL in baseline 
evaluation and during the follow-up among groups related to each kind of treatment.
Results: At baseline, there were no differences in QoL between treatment groups. At 
the 6-month follow-up visit, there was improvement in all groups compared to baseline 
evaluation, (p<0.001). At the 12, 24, 36, and 48-months evaluation, the improvement 
observed at 6 months persisted, in all three strategy therapeutic, however patients 
submitted to CABG presented better QoL when compared with PCI or MT. (p<0.001).
Conclusion: In this study, patients with stable coronary disease and preserved ventricular function 
had improvement in QoL, detected in 6 months which persisted until 48 months. Moreover, the 
CABG and PCI patients presented better improvement QoL when compare to MT.
990-152 Gender Differences in Hospital Survival Rates for 
Medicare Beneﬁciaries Undergoing CABG: Hospital 
Performance Rankings Matter
Phillip P. Brown, Aaron D. Kugelmass, Lynn G. Tarkington, April W. Simon, Edmund R. 
Becker, Steven D. Culler, HCA Clinical Cardiovascular Management Network, Nashville, TN
Background: Numerous studies have reported increased mortality for women undergoing 
CABG. This study examines gender related CABG mortality across hospital performance tiers.
Methods: This is a retrospective analysis that uses the MedPAR ﬁles, a dataset of all 
Medicare beneﬁciaries (MB) discharged in ﬁscal year 2004. Logistic regression analysis, 
controlling for demographic and co-morbid conditions, was used to predict the risk-
adjusted probability of in hospital mortality for each of the 134,707 MB who had CABG 
without valve surgery. The observed and risk-adjusted (expected) number of patients 
(overall and for women and men separately) discharged alive was calculated for all 819 
hospitals performing at least 52 CABG surgeries during ﬁscal year 2004. The risk-adjusted 
number of lives saved (or lost) per thousand patients was calculated for each hospital. 
Hospitals were sorted into quartiles based on the expected total number of lives saved.
Results: For the 819 hospitals in this study, the gender difference in observed survival 
was -1.68% (women = 95.21%, men = 96.89%, p<0.001). The table reports the gender 
difference in lives saved per thousand patients (women - men) by hospital performance 
tier. At top tiered CABG hospitals 10.4 more women/1,000 survived than men, while in the 
bottom quartile 14.5 more men/1,000 survive than women.
Conclusions: Women Medicare recipients can improve their CABG survival rates by 
seeking top performing hospitals based on the Lives Saved performance rankings.
Table: Gender Difference in Risk-Adjusted Lives Saved by Hospital 
Performance Quartiles
1st Quartile 2nd Quartile 3rd Quartile 4th Quartile
Differences in LS/1000 (W-M) +10.44 +4.88 -2.21 -14.51
Average Number of Patients (W,M) (44,93) (58,119) (57,113) (43,89)
 
990-153 Comparison of Factors Identiﬁed as Precipitating Heart 
Failure Hospital Admissions and Clinical Outcomes: A 
Report From OPTIMIZE-HF
Wendy Gattis Stough, Gregg C. Fonarow, Nancy M. Albert, William T. Abraham, Yuliya 
Lokhnygina, Mihai Gheorghiade, Barry Greenberg, Christopher O’Connor, Clyde Yancy, 
James B. Young, OPTIMIZE-HF Investigators and Hospitals, Duke University Medical 
Center, Durham, NC
Introduction: Hospitalization for decompensated heart failure (HF) carries a high risk of 
morbidity and mortality. Whether there is an association between factors identiﬁed at the 
time of hospital admission as contributing to HF exacerbation and subsequent clinical 
outcomes has not been well studied.
Methods: OPTIMIZE-HF is a registry/performance improvement program for pts 
hospitalized with HF. 60-90 day post-discharge follow-up (f/u) data were prospectively 
collected in a pre-speciﬁed 10% sample. Identiﬁable factors contributing to HF 
exacerbation were captured at admission including ischemia, arrhythmia, dietary or 
medication noncompliance, pneumonia/respiratory process, hypertension, and worsening 
renal function (WRF). Multivariable analyses were performed in each group for length of 
stay, in-hospital mortality, 60-90 f/u mortality, and death + rehosp.
Results: 48,612 patients from 259 hospitals were included in this analysis. Mean pt age 
was 72.0 years with 49% women, 78% Caucasian, 42% ischemic etiology, and mean 
LVEF of 36.9%. Pneumonia and WRF were associated with signiﬁcantly worse in-hospital 
mortality risk whereas dietary noncompliance was associated with lower risk (Table 1). 
WRF and ischemia were associated with a higher risk of f/u mortality. Hypertension was 
associated with decreased death + rehosp risk.
Conclusions: Factors contributing to HF admission identiﬁes patients at higher and lower 
risk for adverse outcomes independent of other predictive variables
.
Table 1: Factors Contributing to Heart Failure Admission and Association 
with Outcome
Factor Frequency(%) Length of Stay In-Hospital Mortality Follow-Up Mortality
Follow-Up Mortality/
Rehospitalization
Ischemia 19.1 .99P=.468
1.13
(.96-1.32)
P=.134
1.46
(1.15-1.85)
P=.002
.97
(.82-1.16)
P=.753
Arrhythmia 18.8 1.04P<.0001
.86
(.72-1.02)
P=.083
.77
(.58-1.02)
P=.067
.90
(.76-1.08)
P=.257
Dietary 
Noncompliance 7.4
.95
P<.0001
.67
(.47-.96)
P=.030
.823
(.53-1.29)
P=.393
.92
(.71-1.18)
P=.503
Hypertension 13.3 .96P<.0001
.75
(.56-1.00)
P=.053
.69
(.45-1.06)
P=.090
.68
(.54-.85)
P=.001
Medication 
Noncompliance 10.4
.95
P <.0001
.78
(.59-1.03)
P=.076
1.04
(.72-1.50)
P=.832
.94
(.75-1.17)
P=.558
Pneumonia/
Respiratory Process 18.5
1.09
P <.0001
1.58
(1.36-1.83)
P<.0001
1.22
(.94-1.58)
P=.131
.99
(.82-1.16)
P=.879
Worsening Renal 
Function 8.8
1.08
P <.0001
1.46
(1.21-1.77)
P=.0001
1.44
(1.05-1.97)
P=.023
1.00
(.76-1.29)
P=.971
 
990-154 Elevated Right Atrial Pressure After Heart 
Transplantation Is Associated With Increased Long 
Term Mortality
Eric J. Eichhorn, Katharine Chu, Neil Parikh, Michelle Currier, Judson Hunt, Todd M. 
Dewey, Mitchell J. Magee, J. Edward Rosenthal, Alan Anderson, Morley A. Herbert, 
Michael J. Mack, Medical City Dallas Hospital, Dallas, TX, Cardiopulmonary Research 
Science and Technology Institute, Dallas, TX
Background: Patients with cardiac transplant often have elevated right atrial pressure 
(RAP) post transplant, but it is unclear if this has prognostic relevance.
Methods: Between 8/10/1991 and 8/8/2005 293 patients underwent cardiac 
transplantation at Medical City Dallas Hospital. Of these patients, 215 patients had right 
heart hemodynamics performed at the 2 weeks post transplant biopsy. Patients were 
divided into 2 groups based on the 75th percentile RAP (> 11 mmHg, high RAP) vs 
low RAP ( < 11 mmHg). Mortality during a mean follow-up of 62.9 ± 40.9 months was 
examined by Kaplan Meier methods and comparison by logistic methodology and Cox 
proportional hazards. 
Results:  Baseline characteristics were well matched at baseline between the high and low 
RAP groups with regard to body habitus, age, gender, renal function, heart rate, cardiac 
index, and PA systolic pressure. RAP did not correlate with ischemia time during the 
transplant or prior number of thoracic procedures. RAP did correlate well with pulmonary 
capillary pressure measured at the same time (r=0.36; p<0.001). After controlling for age, 
ischemia time, number of prior chest procedures, proportional hazard analysis showed 
that high RAP was a risk factor for mortality (HR 4.17, 95% CI 1.59-10.95; p=0.004).
Conclusions: Elevated RAP post transplant portends a worse prognosis and is not related 
to either ischemic time during the transplant or prior number of thoracic procedures.
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Barriers to Quality of Care: Adherence 
and Poor Persistance
Tuesday, March 14, 2006, 7:00 a.m.-8:30 a.m.
Georgia World Congress Center, Room B407
7:00 a.m.
834-3 There Is No Objective Evidence That “Self-Referral” Is 
Responsible for Growth of Imaging Services Billed to 
the Medicare System.
Robert A. Book, Lane Koenig, Allen Dobson, Ashley Smith, Audrey El-Gamil, Nikolay 
Manolov, Atul Grover, The Lewin Group, Falls Church, VA
Study Objective: Recent reports have claimed that “self-referral” has been the cause 
of the increase of volume of imaging services billed to the Medicare system. Because 
radiologists are primarily dependent on referrals, differences in the growth rates of 
services primarily performed by radiologists and those performed by non-radiologists 
should illustrate the extent to which self-referral may be driving growth in imaging services. 
Additionally, if self referral is driving growth in imaging utilization, one might expect see an 
increase in imaging services to offset payment reductions. We considered the claim that 
self-referral is an important driver of growth in imaging services by analyzing Medicare 
databases.
Methods: The 1999, 2001, and 2003 Physician/Supplier Summary Master File (PSSMF), 
which includes data from all Medicare Part B carriers and represents procedure-speciﬁc 
billing data for all physician/supplier services. RVU data from the 2005 Medicare Physician 
Fee Schedule was used to develop estimates of the growth in physician service volume. 
We also conducted analyses using the Hospital Outpatient Limited Data Set. Procedure 
codes were grouped in Berenson-Eggers Type of Service (BETOS) categories.
Results: The specialty of radiology dominates the categories related to CT (85%) and 
MRI (65%) , yet these two categories have the highest growth rates among the categories 
examined (16%). This increase in utilization by radiologists at least in theory should not 
be due to self referral. Signiﬁcant decreases in RVU for imaging services was seen in 
2002-2003 period, yet in that same period growth in imaging services remained stable 
and in some cases actually fell.
Conclusion: These ﬁndings suggest that self-referral may not explain the majority of 
growth in imaging services within the Medicare Part B system.
7:15 a.m.
834-4 CV Knowledge and Risk Perceptions Among 
Underserved Individuals at Increased Risk for 
Cardiovascular Disease
Carol Homko, Linda Zamora, Gail Shirk, William P. Santamore, Robert C. Cross, Abul 
Kashem, Judith McCoyd, Timothy McConnell, Francis J. Menapace, Alfred A. Bove, 
Temple University, Philadelphia, PA, Geisinger Medical Center, Danville, PA
Background: Most studies in the general population have found individuals to be overly 
optimistic when estimating their cardiovascular disease (CVD) risk. The purpose of this 
study was to examine knowledge of CVD risk factors and risk perception among patients 
at increased risk for CVD.
Methods: The sample consisted of inner city and rural underserved patients who were 
enrolled in a telemedicine trial to reduce CVD risk. To be eligible for the trial subjects 
were required to have a 10% or greater CVD risk on the Framingham 10 year risk 
index. To assess knowledge of CVD risk factors a 29-item multiple-choice questionnaire 
was created for this study. Subjects also rated their perception of risk as compared to 
individuals of their own gender and age on a 7 point Likert scale with zero representing 
average risk.
Results: Baseline data were available for 264 subjects. The average age of subjects was 
61.2 ± 9.9 years and mean Framingham risk score was 15.8 ± 6.8 %. 59% of participants 
were from rural areas (41% from the inner city), 44% of the sample was female (56% 
male), 18% had diabetes and 8% were smokers. Average knowledge scores were 62.2% 
± 14.7 % and mean levels of risk perception were 0.43 ±1.4. Sub group analysis revealed 
that women had a signiﬁcantly lower actual risk than their male counterparts (14.1 ± 5.7 
% verus17.1 ± 7.3%; p <0.001) but that their perceived risk was signiﬁcantly higher (0.7 ± 
1.3 versus 0.2 ± 1.4; p< 0.05). Women were also more knowledgeable than men (65% ± 
15% versus 60% ± 14%; p<0.05) about CVD. When subjects from rural and urban areas 
were compared, no differences were found in actual risk (15.4 ± 7.1% versus 16.4± 6.3 
%; NS). However subjects from the inner city were signiﬁcantly less knowledgeable about 
heart disease (55% ± 14%versus 67% ± 13%; p<0.001) and also perceived their risk to 
be lower (0.15 ± 1.5 versus 0.61 ± 1.3; p < 0.05).
Conclusions: Overall, these results indicate a low perception of risk and CVD knowledge 
for all participants, especially pronounced among men and inner city residents, despite 
the magnitude of their actual risk. Innovative educational strategies are needed to 
increase risk factor knowledge and awareness among at risk individuals.
7:30 a.m.
834-5 The Effects of Statin Copayments and Statin Adherence 
on Medical Care Utilization and Expenditures
Teresa B. Gibson, Tami L. Mark, Kirsten Axelsen, Onur Baser, Joan A. Mackell, 
Heidi King, Kimberly A. McGuigan, Thomson Medstat, Ann Arbor, MI, Pﬁzer Global 
Pharmaceuticals, New York, NY
Background We examined the effects of statin prescription drug copayments and statin 
adherence on cardiovascular utilization patterns and other outcomes of statin therapy.
Methods The 2001-2003 MarketScan database was used to study the health care 
utilization and expenditure patterns of 93,296 continuously enrolled statin users in 
employer sponsored health plans. A two-stage estimation approach included a multivariate 
logit model that estimated the relationship between copayments and adherence in June 
2001 through December 2002. Generalized Linear Models were estimated to examine the 
effects of adherence on utilization patterns and expenditures in 2003.
Results Higher copayments led to lower levels of statin adherence (Odds Ratio 0.75 
p<.01). Higher levels of statin adherence were associated with fewer adverse events: 
hospitalizations, cardiovascular hospitalizations and emergency room visits (see table). 
Adherent patients had a larger number of physician ofﬁce visits and higher prescription 
drug expenditures but medical expenditures and total expenditures for these patients 
were not signiﬁcantly different from nonadherent patients. 
Measure Effect of Statin Adherence on Measure
p-
value
Expenditures Partial Elasticity
Total Expenditures (Prescription Drug and 
Medical) .158 .105
Medical Expenditures .146 .389
Prescription Drug Expenditures .204 .001
Utilization Odds Ratio
Physician Ofﬁce Visits 14.84 <.001
Emergency Room Visits .219 <.001
Hospitalizations .419 .012
Cardiovascular-related Hospitalizations .425 .046
Conclusion Statin copayments serve as a ﬁnancial barrier to statin adherence. Lower 
levels of adherence are associated with adverse cardiovascular and medical outcomes. 
Policymakers and plan managers should consider the effects of higher copayments on 
adherence, utilization patterns and clinical events for patients with hyperlipidemia.
7:45 a.m.
834-6 Patients’ Pill Burden Predicts Adherence to 
Antihypertensive and Lipid-lowering Therapy
Joshua S. Benner, Allison A. Petrilla, J. Sanford Schwartz, Simon Tang, Noah 
Rosenberg, Richard H. Chapman, ValueMedics Research, LLC, Falls Church, VA, 
School of Medicine and Wharton School, University of Pennsylvania, Philadelphia, PA
Background: Patients on multiple medications have been reported to have low adherence 
to antihypertensive (AH) and lipid-lowering (LL) therapy, but the incremental effect of each 
additional medication has not been described.
Methods: To quantify the impact of incremental pill burden on adherence to AH and 
LL therapy, a retrospective cohort study was conducted in a US managed care plan 
among patients initiating AH and LL therapy within a 90-day period. Proportion of days 
covered (PDC) by AH and LL drugs was calculated for the ﬁrst year of concomitant 
therapy, with patients considered adherent if they had PDC ≥80% for both classes. Pill 
burden was deﬁned as the total number of prescription medications taken in the year 
before AH and LL treatment. Correlation between pill burden and PDC was measured, 
and logistic regression was used to quantify the association between pill burden and 
likelihood of being adherent, adjusting for demographic, clinical, and health services use 
characteristics. A separate model tested multiplicative interactions between pill burden 
and these characteristics.
Results: Of 8406 new users of AH and LL therapy, 46.9% were female; 48.2% were ≥65 
years of age; 31.7% had a history of CHD; and 9.5% had a history of stroke. Mean (SD) 
number of medications in the baseline year was 4.0 (3.9). Mean (SD) PDC was 45.2% 
(31.3%); the median was 40.9%. In patients with 0, 1, and 2 other medications in the 
baseline year, median PDC was 58.8%, 48.6%, and 42.0%, respectively. For those who 
took 8, 9, and ≥10 medications in the baseline year, median PDC was 32.7%, 28.3%, and 
24.5%, respectively. The inverse correlation between pill burden and PDC was moderate 
(Spearman’s r = -0.19; p<0.0001); regression models indicated a curvilinear relationship 
in which incremental pill burden had the greatest effect on adherence in patients taking 
the fewest medications. The effect of pill burden on adherence was constant for all levels 
of demographic, clinical, and health services use variables.
Conclusions: Pill burden is a signiﬁcant independent predictor of adherence to 
concomitant AH and LL therapy. The impact of each additional medication appears to be 
greatest in patients taking the fewest medications at baseline.
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834-7 The Impact of Medication Non-adherence on 
Hospitalization and Mortality Among Patients With 
Diabetes
P. Michael Ho, John S. Rumsfeld, Frederick A. Masoudi, David L. McClure, Mary E. 
Plomondon, John F. Steiner, David J. Magid, Denver VA Medical Center, Denver, CO, 
Kaiser Permanente of Colorado, Denver, CO
Background: Medication non-adherence may reduce the effectiveness of therapies. 
However, the association between medication non-adherence and mortality remains 
unexplored outside the context of clinical trials.
Methods: This was a retrospective cohort study of 11,532 patients with diabetes in a 
Managed Care Organization. Medication adherence was calculated as the proportion of 
days covered (PDC) for ﬁlled prescriptions of oral hypoglycemics, antihypertensives and 
statin medications. The primary outcomes were all-cause hospitalization and all-cause 
mortality. Multivariable regression analyses were employed to assess the independent 
association between medication non-adherence and outcomes.
Results: Non-adherent patients (PDC <80%; prevalence 21.3%) were younger and had 
fewer co-morbidities. During follow-up, non-adherent patients had higher hemoglobin 
A1C, low-density lipoprotein cholesterol, systolic and diastolic blood pressures. In 
unadjusted analysis, non-adherent patients had higher all-cause hospitalization (23.2% 
vs. 19.2%; p<0.01) and higher all-cause mortality (5.9% vs. 4.0%; p<0.01). In multivariable 
analyses, medication non-adherence was associated with a 36% increase in relative risk 
for all-cause hospitalization (RR 1.36; 95% CI 1.24-1.48; p<0.01), and a 72% increase in 
relative risk for all-cause mortality (RR 1.72; 95% CI 1.42-2.08; p<0.01). The ﬁndings were 
consistent among high-risk subgroups.
Conclusions: Medication non-adherence is prevalent among patients with diabetes and is 
associated with adverse outcomes. Assessment of medication non-adherence should be 
incorporated into routine clinical practice. Interventions are needed to increase medication 
adherence so that patients can realize the full beneﬁt of prescribed therapies.
8:15 a.m.
834-8 Effect of Physician Financial Incentives and Clinical 
Information Systems on Medication Use and 
Congestive Heart Failure Admissions
Shaista Malik, Susan Ettner, Joe Selby, Ted Thompson, Bob Gerzoff, David Curb, Bill 
Herman, Carol Mangione, University of California, Los Angeles, Los Angeles, CA, 
University of California, Irvine, Irvine, CA
Introduction: Various organizational strategies have been used to improve quality 
of care in persons with diabetes. We concurrently examined effects of cardiovascular 
care management strategies, provider ﬁnancial incentives, and organizational model 
on appropriate cardiovascular medication use, intermediate cardiovascular outcomes, 
congestive heart failure admissions, and cardiovascular mortality using the Translating 
Research Into Action for Diabetes (TRIAD) study data.
Methods: Using data from 57 provider groups in seven states and a sample of 9746 
patients with diabetes in 2000 and 2001, we constructed multi-level models, adjusted for 
patient demographic and clinical characteristics to assess the relationship between our 
provider group level variables and patient processes and outcomes.
Results: We found that higher intensity use of clinical information systems was associated 
with higher beta blocker use (OR=1.41, p=.05) and fewer congestive heart failure 
admissions (OR= 0.55, p=.01). We also found that aligning provider ﬁnancial incentives 
with quality resulted in higher rates of lipid lowering therapy (OR=1.24, p=.01), fewer 
patients out of control for LDL-C (OR=.68, p=.03), and lower congestive heart failure 
admissions (OR=.41, p=.03). Financial incentives that promoted a provider’s gatekeeping 
role resulted in lower rates of lipid lowering therapy (OR=0.80, p=.02), more patients 
out of control for LDL-C (OR=1.55, p=.05) and higher rates of congestive heart failure 
admissions (OR=2.03, p=.05).
Conclusion: Use of clinical information systems and alignment of provider ﬁnancial 
incentives with quality led to better processes and outcomes, while incentives directed 
at increasing a provider’s gatekeeping role were associated with worse processes and 
outcomes.
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1012-145 Automated Pericardial Fat Quantiﬁcation in CT Data
Ioannis Kakadiaris, Alok Bandekar, Khawar Gul, Song Shou Mao, Junichiro Takasu, 
Matt Budoff, Morteza Naghavi, University of Houston, Houston, TX
Background: Fat tissue is no longer viewed as a simple energy storehouse of the body but 
as an active organ with critical metabolic and immune regulatory functions. Periadventital 
and pericardial fat have been recently identiﬁed to play a role in coronary atherosclerotic 
plaques. We therefore sought developing noninvasive automated measurement of 
pericardial fat by CT.
Methods: We have developed an automatic tissue segmentation method based on 
fuzzy afﬁnity to quantify pericardial fat in CT. Our technique combines the image intensity 
and texture information with the anatomical data. Speciﬁcally, we have created a novel 
3D template of the thoracic cavity and subsequently ﬁtted it to the data using texture 
information.
Results: We have compared the results of our method with human expert manual 
segmentation of pericardial fat in 163 subjects. The mean accuracy for pericardial fat 
was 99.46% ± 0.26%. The mean true negative value was 99.58% ± 0.15% and ﬁnally, 
the mean true positive value was 91.48% ± 11.10%. An evaluation of the accuracy of our 
method indicates bias and limits of agreement comparable to the inter-observer variability 
inherent in manual segmentation.
Conclusion: We have developed a fully automated pericardial fat measurement technique 
based on CT imaging. This technique does not require seed initialization, correlates very 
well with manual readings by human and is much faster. Clinical investigation of this tool 
is warranted to evaluate the role of pericardial fat in risk assessment.
1012-146 Intravascular Ultrasound-Based Imaging of Vasa 
Vasorum for the Detection of Vulnerable Atherosclerotic 
Plaque
Ioannis Kakadiaris, Sean. O’Malley, Manolis Vavuranakis, Stephane Carlier, Craig 
Hartley, Ralph Metcalfe, Roxana Mehran, Morteza Naghavi, University of Houston, 
Houston, TX
Background: Intravascular ultrasound (IVUS) is the best clinically-available tool for 
morphological characterization of plaques today. However, the inability of IVUS to 
measure plaque inﬂammation limits its value in the detection of vulnerable plaques. 
Previous autopsy studies have shown an increased density of vasa vasorum (VV) in 
culprit plaques. We sought to investigate whether VV could be detected by IVUS using an 
intracoronary injection of microbubble contrast agent.
Methods: To date we have evaluated 8 patients. The IVUS catheter was positioned at 
the site of the minimal lumen area of an angiographically moderate coronary stenosis. 
A bolus of microbubbles was injected through the guiding catheter. IVUS data were 
continuously collected before, during, and after injection for a matter of minutes. VV 
detection and quantiﬁcation were accomplished through temporal enhancement analysis 
using difference imaging techniques.
Results: We have observed signiﬁcant enhancement in the adventitia of 8 pts and in 
the plaque of 7 pts. The average enhancement was 1.2% and 3.2% over the adventitia 
and the plaque, respectively. The ﬁg. shows a baseline IVUS image before i.c. Optison 
injection, and a mapping of the maximal increase in echogenicity observed over 2 min.
Conclusion: This is the ﬁrst demonstration of the possibility to perform in vivo density and 
perfusion imaging of the vasa vasorum of coronary plaques. Extensive investigations in 
different clinical settings and further validation are warranted.
 
1012-147 A Novel Two-Dimensional Echocardiographic Image 
Analysis System Using Artiﬁcial Intelligence Shape 
and Pattern Recognition for Rapid Automated Ejection 
Fraction
Maxime Cannesson, Matthew S. Suffoletto, Masaki Tanabe, Dennis M. McNamara, John 
Gorcsan, III, University of Pittsburgh, Pittsburgh, PA
Background: Ejection fraction (EF) by two-dimensional echo is important clinically but 
manual tracing is time-consuming and routine visual assessment is inherently subjective. 
The aim of this study was to test the hypothesis that a novel 2D echocardiographic image 
analysis system using artiﬁcial intelligence pattern and shape recognition can rapidly and 
reproducibly calculate EF.
Methods: We studied 137 patients including 107 with abnormal left ventricular (LV) 
function (67% ischemic disease). Auto EF (Siemens Corp), applied to routine digital 
images, incorporated programming previously “trained” on >500 human EF tracings to 
automatically locate the LV, track the endocardium, and calculate EF in < 15 sec. Results 
were independently compared with manually traced biplane Simpson’s rule by another 
investigator blinded to the Auto EF results.
Results: Auto EF was possible in 130 of 137 (95%) consecutive patients. Auto EF 
correctly traced and tacked endocardium completely automatically in 83% of patients 
and required some manual editing in only 17% despite a wide range of LV volumes (from 
46 to 446 ml) and functions (EF ranged from 9 to 71 %). Auto EF correlated well (r=0.99, 
bias=0.5%, limits of agreement=6%) with manual tracing and required less time (55±32 
vs. 102±21 sec, respectively p<0.01).
Conclusions: Auto EF can automatically and rapidly calculate EF similar to results by 
manual biplane Simpson’s rule and has clinical potential application
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1012-148 Closed-loop Automated Drug Delivery to Optimize 
Systemic Arterial Pressure, Cardiac Output, and Left 
Heart Filling Pressure in Discompensated Heart Failure
Atsunori Kamiya, Kazunori Uemura, Shuji Shimizu, Masaru Sugimachi, Kenji 
Sunagawa, National Cardiovascular Centre Research Institute, Suita-City, Japan
Pharmacological support with inotropes and vasodilators to control discompensated 
hemodynamics requires strict monitoring patients condition and frequent adjustments of 
drug infusion rates, which is difﬁcult and time-confusing, especially in hemodynamically 
unstable patients. To overcome this difﬁculty, we have developed a novel automated 
drug delivery system for simultaneous control of systemic arterial pressure (AP), cardiac 
output (CO), and left atrial pressure (LAP). The circulatory equilibrium framework 
developed previously indicates that AP, CO and LAP are determined by an equilibrium 
of the pumping ability of the left heart (SL), stressed blood volume (V) and systemic 
arterial resistance (R). Our system directly controls SL with dobutamine, V wirh dextran/
furosemide, and R with nitroprusside, thereby controlling the three variables of AP, CO 
and LAP. We evaluated the efﬁcacy of the system in 12 anesthetized dogs with acute 
decompensated heart failure. Once activated, the system restored SL, V and R within 30 
minutes, resulting in the restoration of normal AP, CO and LAP. Steady state deviations 
from target values were small for AP [(4.4 mmHg (SD 2.6)), CO [5.4 ml•min-1•Kg-1 (SD 
2.4)] and LAP [0.8 mmHg (SD 0.6) ]. In conclusion, by directly controlling the mechanical 
determinations of circulation, our system has enables simultaneous control of AP, CO and 
LAP with good accuracy and stability.
1012-149 Reliability of Cardiac Index Monitoring With an Analysis 
of Peripheral Arterial Waveform During Varing Loading 
Condition in Vivo
Yusuke T. Imuro, Junya Shite, Toshiro Shinke, Satoshi Watanabe, Hiromasa Otake, 
Daisuke Matsumoto, Oscar Luis Paredes, Daisuke Ogasawara, Takahiro Sawada, 
Mitsuhiro Yokoyama, Kobe University, Graduate School of Medicine, Kobe, Japan
Background: PulseCOTM monitor is a novel instrument that analyzes peripheral arterial 
waveform. This can calculate instantaneous cardiac index (CI) with single time calibration 
with Fick’s method CI (F-CI). We previously reported P-COTM derived CI (P-CI) was 
identical to the value of Fick’s method CI (F-CI) not only in patients with normal cardiac 
function but also in patients with cardiac dysfunction. But the reliability of P-CI during 
changing loading condition is unknown.
Methods: F-CI and P-CI were measured in 14 congestive heart failure (CHF) patients (8 
men and 6 women) before and after injection of nitroglycerin (NTG:1.5-2.5mg).
Results: Systolic blood pressure decreased from 134.3+6.4 to 111.4+3.6mmHg and 
vascular resistance decreased from 2,481+215 to 2,018+153 dynes.sec.cm-5.m2 after 
NTG injection. P-CI increased from 2.44+0.20 to 3.00+0.20L/min/m2 and F-CI increased 
from 2.51+0.18 to 3.03+0.20 L/min/m2 after NTG injection. Relation between P-CI and 
F-CI was excellent both before and after NTG injection (before NTG; r=0.959, p=0.0001, 
the calibrating coefﬁcient=1.026+0.027, after NTG; r=0.977, p=0.0001, the calibrating 
coefﬁcient=1.023+0.017).
Conclusions: We suggest P-CI is accurate also in case of varying systemic blood 
pressure and vascular resistance in patient with CHF.
 
1012-150 A New Technique for Coronary Digital Subtraction 
Angiography
Takeshi Nakaura, Satoru Oishi, Kazuo Awai, Yasuyuki Yamashita, Graduate School of 
Medical Sciences, Kumamoto University, Kumamoto, Japan, Toshiba Medical Systems 
Corp., Otawara, Japan
Background: Digital Subtraction Angiography(DSA) is commonly used to enhance only 
vessel structures, but is not applicable for coronary angiography because of heartbeat. 
We have developed new automatic subtraction technique for coronary DSA.
Methods: Sixty angiographic series of twenty patients were enrolled in this study. Our 
technique consists of four steps. The ﬁrst step divides images into two sets, one and 
another sets have less and sufﬁcient contrast enhancement, respectively. The former and 
latter sets are called mask and contrast data sets, respectively. The second step detects 
region of interest(ROI), which has less contrast enhancement in all frames. The third 
step determines best mask image for each contrast image with similarity into the ROI. 
The similarity is determined with cross-correlation coefﬁcients. The last step subtracts 
best mask image from each contrast image. Two radiologists evaluated both visibility 
of arteries and artifacts in consensus. Image quality was assessed by using a 5-point 
grading. Grade 4 or 5 were assessed as acceptable quality for diagnostic purposes.
Results: In 56 of 60 series (93.3%), radiologists evaluated those subtraction images 
were grade 4 or 5. They also pointed out that small arteries and myocardial enhancement 
were clearly detectable as shown in ﬁgures.
Conclusions: Our new technique has achieved coronary DSA, and evaluation 
results demonstrated improved detection of both ﬁner arteries and slighter myocardial 
enhancement.
1012-151 A Simple Algorithm for Accurate Detection of Atrial 
Fibrillation in an Ambulatory Monitor
David T. Linker, Robert W. Rho, University of Washington, Seattle, WA
Background: The incidence of asymptomatic paroxysmal atrial ﬁbrillation (AF) is signiﬁcant 
even in patients with symptomatic episodes of AF. Ambulatory detection of asymptomatic 
AF is currently difﬁcult. Current monitoring devices are limited by dependence on patient 
activation, insensitive detection algorithms and limited storage capacity. An accurate, and 
reliable algorithm for detecting all asymptomatic atrial ﬁbrillation events in an ambulatory 
monitoring device would allow quantiﬁcation of individual’s clinical AF burden.
Methods: An algorithm for discriminating sinus rhythm from atrial ﬁbrillation was 
developed, and tested using ambulatory monitor recordings from the Physionet database. 
Segments identiﬁed as AF or normal sinus rhythm were used from the AF and sinus 
rhythm databases respectively. The QRS time of arrival from the QRS annotations were 
used to derive the measures of local variability of the heart rate, which was used to 
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discriminate between atrial ﬁbrillation and normal sinus rhythm.
Results: A total of 405,825 beats during atrial ﬁbrillation and 1,448,475 beats during 
normal sinus rhythm were used in the analysis. A non-linear measure of the local 
variability gave the best results, with an area under the receiver operating curve of 0.9954. 
Using this measure, we could achieve a sensitivity of 98.0% and a speciﬁcity of 97.2% for 
classiﬁcation of a 7 beat segment. The algorithm can be implemented with only integer 
calculations, making it suitable for a low-powered, battery device. The high speciﬁcity will 
limit storage requirements by limiting storage of normal sinus rhythm.
Conclusions: A simple algorithm can achieve high sensitivity and speciﬁcity for the 
detection of atrial ﬁbrillation. Further analysis of the algorithm’s performance in the 
presence of other rhythm disturbances is necessary. Such a device may guide safe 
withdrawal of anticoagulation and more accurately assess efﬁcacy of rhythm control 
interventions.
1012-152 An On-Line, Evidence-Based Calculator of Mortality in 
Congestive Heart Failure Based on Clinical Variables
David T. Linker, Wayne C. Levy, University of Washington, Seattle, WA
Background:Heart failure mortality is highly variable, and dependent on a number of 
known factors. Easily determining the projected mortality, and the beneﬁt of interventions, 
would be useful for treatment planning and patient counseling.
Methods:We used a previously described model of mortality in heart failure, called 
the Seattle Heart Failure Score, which was developed using analysis of the PRAISE1 
database, and validated in ﬁve additional datasets, for a total of 11,067 subjects. The 
model uses easily-obtained clinical data to estimate baseline mortality, and the results of 
therapeutic interventions. We created a web-based calculator using an interactive, Java 
applet, allowing on-line entry and modiﬁcation of the data from any Java-enabled web 
browser (see ﬁgure).
Results:The web-based calculator allows easy and rapid calculation of the projected 
baseline mortality and effect of interventions. It is in a format suitable for use either by 
clinicians or for discussion with patients.
Conclusions:We have developed a web-based calculator of projected mortality at 
baseline and after interventions for patients with congestive heart failure. This should be 
of use to clinicians to in planning therapy and enhancing compliance with therapy. 
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1013-145 CABG and PCI Rates Differ Between Genders Even With 
Similar Coronary Anatomy: A Computer Based Patient 
Simulation Explores the Gender Gap
Brandon M. Meyers, Chi-Ming Chow, Beth L. Abramson, Division of Cardiology, St. 
Michael’s Hospital, University of Toronto, Toronto, ON, Canada
Background: Gender differences exist in the rates of cardiac revascularization. We 
evaluated whether gender-bias contributes to these differences by creating a computer 
simulation tool.
Methods: Six gender-matched clinical vignettes with coronary angiograms were shown 
to 43 specialists (total of 258 patient scenarios). Within the gender-matched pairs, we 
controlled for age, co-morbidities, and symptoms. In this pilot study, specialists were 
surveyed on management and rationale, but were blinded to our hypothesis.
Results: Decisions on the rate of medical therapy were similar between genders (21.7% 
male (M) Vs. 20.2% female (F) of total). For the left anterior descending artery (LAD), 
CABG was selected more often in M (53.2% Vs. 39.2% in F; p<0.05); similar results were 
found for the circumﬂex (CX). Conversely, bare metal stent (PCI) rates were higher in F 
than M for the LAD and CX (Table 1). When PCI rates included drug-eluting stents (PCI+), 
the effect only remained for the CX (Table 1). No gender differences were found for the 
right coronary artery (RCA). Logistic regression of CABG and PCI rates demonstrated a 
trend of gender inﬂuencing intervention (both p=0.06).
Conclusions: When surveyed, we found gender differences in types of revascularization 
cardiovascular specialists suggested even when we controlled for anatomy and co-
morbidity. This pilot data suggests specialist preferences may be partially responsible for 
the gender gap in revascularization rates and requires further exploration.
Table 1: PCI Rates with and without drug-eluting stents
PCI PCI+
% LAD CX RCA Overall LAD CX RCA Overall
M 19.5 32.9 28.9 27.1 46.8 46.8 55.4 49.7
F 37.8 47.2 35.2 40.1 60.8 68.5 63.4 64.2
p-value <0.05 <0.05 ns ns <0.05 ns
 
1013-146 Decision Support for Coronary Revascularization
Todd A. Mackenzie, William C. Nugent, Craig W. Langner, M. Theodore Silver, David 
J. Malenka, Reed D. Quinn, Mirle A. Kellett, Jr., Donato Sisto, Richard A. Boss, David 
C. Charlesworth, Bruce J. Leavitt, Richard P. Cochran, Elaine M. Olmstead, Gerald 
T. O’Connor, Dartmouth Medical School, Lebanon, NH, Northern New England 
Cardiovascular Disease Study Group, Lebanon, NH
Background: Many clinical prediction rules for short-term mortality following coronary 
revascularization have been developed, validated, and introduced into routine clinical 
practice. Few rules exist for predicting long-term survival in the modern era of coronary 
revascularization. We report on the development and validation of models for predicting 
long-term survival following CABG and PCI based on recent experience. Methods: 
We linked 1987-2001 CABG and 1992-2001 PCI data from our Northern New England 
registries on 95,000 patients to the National Death Index, ascertaining 16,000 deaths 
during 440,000 person-years. Cox’s semi-parametric model and its generalizations to 
non-proportional hazards and non-linear log-hazards were used to regress survival on 
patient risk factors. These prediction models were incorporated into easy-to-use software. 
Results: The Harrell concordance index ranged from 75% to 83%, depending on 
procedure and period (0-30 days, 31-365 days, > 1 year). The ﬁgure depicts the predicted 
survival for a 65 year old male with a 35% ejection fraction, diabetes, 3-vessel disease, 
1.2 mg/dl creatinine and an 8,000 white blood cell count. Summary: We developed and 
validated models that accurately predict long-term survival following CABG and PCI as 
currently performed. These models use routine clinical data, can be solved with available 
software, and should be used to enhance informed, patient-centered clinical decision 
making on the choice of revascularization procedure.
1013-147 Pediatric EKG: A Computer Aided Approach Reducing 
Common but Important Errors
Marcos S. Molina, Alexandre M. Benjo, Alessandra I. Molina, Desiderio Favarato, Zilda 
S. Benjo, Nancy Tobias, Antonio CP Chagas, Jose A. Ramires, Carlos A. Pastore, Heart 
Institute of Sao Paulo University, Sao Paulo, Brazil, Johns Hopkins Hospital, Baltimore, MD
Background: The EKG is still an important piece on the pediatric cardiologic diagnosis, 
especially in third world countries. As there are 12 age groups and 12 twelve segments to 
be analyzed, the pediatric EKG interpretation is considered by many physicians, including 
cardiologists, a difﬁcult task. The conventional analysis based on the physician’s memory 
or on a quick reference to a standard table of reference could damage the ﬁnal result of 
the evaluation, and so the patient. We developed a software intending to help physicians 
on this task.
Methods: To validate the software we selected as reference 4 normal and 1 altered 
EKGs with concordant reports given by 2 pediatric electrocardiographists using manual 
planimetry. Nineteen certiﬁed cardiologists examined each of them at least 2 times, once 
using the normality reference table and other time using the systematized software aid, 
entering manually the measurements on the computer analyzing 120 EKG segments 
each, a total of 2280. We called Important Errors (IE) the ones with potential to lead to 
misdiagnose, in the presence of them the physician was asked to interpret a third time the 
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EKGs using both aids simultaneously. Statistically we used logistic regression accepting 
a p < 0.05 as signiﬁcant.
Results: When using just the reference table there were 95(8.3%) errors, the software aid 
decreased the global errors in 83% to 16 (1.4%) (p < 0.01). Using conventional analysis 
there were 36 EKGs (37.9%) with IE comparing to 8 EKGs (8.4%) with IE using the 
software, a 78% reduction (p<0.01). Combining both skills there was a reduction in IE to 
2 and 1 EKGs with, a 94.7 and 87.5% decrease respectively (p<0.01 in both cases). The 
errors observed during the analysis were, as related by the physicians, due to analyst’s 
low visual sharpness (88%) or carelessness (12%).
Conclusions: The computerized aid to pediatric EKG demonstrated to be an efﬁcient and 
safe complementary tool, even better if used in association with traditional techniques. It 
still remains to be tested training proprieties of the software. This software is being revised 
to be a freeware at www.clinicasaopaulo.com.br.
1013-148 A Virtual Classroom is Superior to Traditional Training 
in Teaching Cardiac Auscultation
Michael Barrett, Mary Ann Kuzma, Katherine Thomas, Tyler Seto, Kathleen Ryan, 
Arnold Smolen, Drexel University College of Medicine, Philadelphia, PA
Background: The ability of medical students to recognize heart sounds is poor. Previous 
work has demonstrated that listening to high grade repetition of abnormal heart sounds 
in a classroom dramatically improved proﬁciency in cardiac auscultation. In this study, 
we compared the effect of listening to heart sounds in a virtual classroom (Group A) to 
traditional instruction in cardiac auscultation (Group B).
Methods: Group A consisted of 235 third year medical students who logged onto a web site 
and took a computer-based test in cardiac auscultation. Students then downloaded a one-
hour digital audio ﬁle containing auditory recognition exercises of 5 basic murmurs ( AS, AR, 
MS, MR, Innocent Murmur) and 2 extra heart sounds (S3, S4). These auditory exercises 
were composed of 200 repetitions of each heart sound. Three weeks later students returned 
to the web site to take a post test. At both tests, students listened to human heart sounds in 
a randomized sequence and selected the correct answer from a menu. Group B consisted 
of 103 third year students who received traditional training in cardiac auscultation and took 
the same computer-based test at the end of their third year.
Results: The pretest average score of Group A was 31.5 +/- 20.9% and increased 
signiﬁcantly to 80.5 +/- 16.31% on the post test, p<.001 by paired t-test. These post test 
scores were signiﬁcantly higher than the year end scores of Group B: 35.2 +/- 18.2%, 
p<.001.
Conclusions: A virtual classroom consisting of a web site with a digital audio ﬁle of 
auditory recognition exercises produced dramatic improvement in medical students’ 
proﬁciency in cardiac auscultation. These results were superior to those obtained by 
traditional training in cardiac auscultation. This study supports the hypothesis that clinical 
skills such as cardiac auscultation can be effectively taught over the internet.
1013-149 Virtual Cardiac Symposia: World Wide Internet Based, 
Educational Forums for Cardiologists
Sergio J. Dubner, Edgardo Schapachnik, Andres R Perez Riera, Arthur Moss, Woijciech 
Zareba, on behalf of the Education Committee of ISHNE, Clinica y Maternidad Suizo 
Argentina, Buenos Aires, Argentina, University of Rochester Medical Center, Rochester, NY
Background: Traditional aspects of postdoctoral cardiac education have included 
attendance at regional and national meetings and knowledge gained from reading 
cardiology journals. The use of internet opens a new educational option and can provide 
effective education to a very large audience.
Objective: To demonstrate the power of world-wide, internet-based educational 
activities
Methods: We recently performed 4 successful internet-based virtual cardiac symposia 
focused on the Brugada Syndrome (Brugada), the Long Q-T interval syndrome (LQTS), 
Arrhythmogenic Right Ventricular Dysplasia (ARVD) and Atrial Fibrillation (AF) (ongoing 
- October 1st - October 31st, 2005). Each virtual symposium consists of lectures, webcast, 
radio interview, and interactive forums. Selected, world-class experts in a given cardiac 
disorder deliver the key lectures and run each conference and are available to provide 
answers to diagnostic and therapeutic questions from practicing cardiologists
Results: 
BRUGADA LQTS ARVD AF
Honorary President P. Brugada A. Moss F. Marcus - G. Fontaine J. Camm
Registrants 1,800 2,716 3,147 7,040
Countries 22 48 75 85
Duration (days) 30 30 15 30
Downloaded lectures No data 23800 28736 In process
Submitted questions 99 245 151 In process
Top lecture downloaded 916 No data 5980 In process
Conclusions: The responses from cardiologists around the world exceeded our 
expectations. The large number of favorable comments by the registrants after completion 
of the ﬁrst three programs indicates that this approach answers an unmet need and adds 
an important new, low-cost dimension to continuing medical/cardiologic education.
1013-150 The Impact of an Electronic Stethoscope as a Patient 
Simulator in Cardiac Auscultation
Michael J. Barrett, Amit Patel, Howard Kramer, Archana Saxena, Alfred Bove, Temple 
University School of Medicine, Philadelphia, PA
Background: The proﬁciency of medical residents in cardiac auscultation is alarmingly 
low ( only 21% identify murmurs correctly). Previous work demonstrated signiﬁcant 
improvement following intensive repetition of abnormal heart sounds. The emergence 
of electronic stethoscopes with memory tracks allowed us to test the hypothesis that 
electronic stethoscopes can be used as patient simulators to provide the necessary 
repetition to improve proﬁciency in cardiac auscultation
Methods: Twenty six medical residents took a pretest and then were randomized to 
intervention (16) or control (10). The subjects in the intervention group were given an 
electronic stethoscope (E 4100, 3M-Littmann) with 6 memory tracks preloaded with 6 
simulated cardiac murmurs (AS,AR,MR,MS, MVP, Innocent Systolic Murmur). Intervention 
subjects listened to 500 repetitions of each murmur in a monitored setting over a 2 hour 
period. Control subjects did not have access to the electronic stethoscope. All subjects 
took a pretest and posttest consisting of human heart murmurs played in random order.
Results: Intervention subjects’ correct answers improved from 26.2 +/- 20% on pretest 
to 68.7 +/- 25% on the posttest, p<.001 by paired t-test. Controls had a non signiﬁcant 
change from 37 +/- 15% on the pretest to 46 +/- 15% on the posttest, p=.22. The difference 
in the change between the 2 groups was signiﬁcant at p=.005.
Conclusions:An electronic stethoscope can function effectively as a patient simulator to 
provide the necessary repetition to dramatically improve medical residents’ proﬁciency in 
cardiac auscultation. These results show that cardiac auscultation is, in part, a technical 
skill that can be learned through repetition. This study suggests a novel approach to 
improve this important clinical skill using an electronic stethoscope.
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847-3 Catholic Healthcare Partners’ Closing the Gap for Heart 
Failure Initiative: A Large Multistate Health System 
Takes on the Challenge to Inprove Quality of Care
Donald E. Casey, Jr., William Abraham, Lynn Barrow, Margaret Namie, Ileana Piña, 
John Schaeffer, Richard Snow, Catholic Healthcare Partners, Cincinnati, OH
The Catholic Healthcare Partners (CHP) Heart Failure GAP Partnership is designed to 
develop and implement a broad reaching quality improvement initiative for heart failure 
(HF) care management based upon translating research into practice. The initiative has 
several goals: (1) Establishing and sustaining a broad-based partnership of national and 
local HF experts and stakeholders that energizes and enhances the ability of a large, 
multi-state health system of 30 hospitals to improve heart failure care on a far-reaching 
scale (2) Overcoming current organizational and health system challenges for patients 
with HF via 6 “Heart Failure (HF) Advocates” specially trained through the National 
Heart Failure Training program (“NHeFT”) (3) Developing and implementing a variety of 
special information technology prototypes for Electronic Health Records (EHRs), patient 
management, and Quality Improvement data tools based upon the 2005 ACC/AHA 
Clinical Performance Measures for Adults with Chronic Heart Failure. Key results to date 
are noted in the table. 
CHP Summary HF Quality Improvement Data
Q4 2002 Q2 2005
ACE/ARB usage 77% 91%
Left Ventricular Ejection Fraction Assessment 78% 97%
Appropriate Discharge Instructions 36% 90%
Adult Smoking Cessation Counseling 47% 98%
Inhospital Mortality (annualized) 4.00% (2002) 3.65% (2004)
30-day all cause readmission rate for HF (annualized 21.4% (2002) 19.0% (2004)
The HF Advocates have evaluated more than 3,500 patients in 12 months and 
readmission rates for these patients have been consistently less than 5%. The structure 
and characteristics of the Partnership will be described in detail, including opportunities 
and insights for replication by other large health systems and community-based 
collaboratives interested in improving HF care. HF Advocate progress and implementation 
of IT prototypes will also be described.
11:12 a.m.
847-4 Do Hospitals That Provide Heart Failure Patient 
Education Prior to Discharge Also Promote Continuity 
of Care? A Report from OPTIMIZE-HF
Nancy M. Albert, Gregg C. Fonarow, William T. Abraham, Karen Chiswell, Wendy 
Gattis Stough, Mihai Gheorghiade, Barry Greenberg, Christopher M. O’Connor, Clyde 
Yancy, James B. Young, OPTIMIZE-HF Investigators and Hospitals, Cleveland Clinic 
Foundation, Cleveland, OH
Introduction: Whether hospitals that successfully apply heart failure (HF) pt education 
techniques pre-hospital discharge (dc) also promote continuity of care by referral to 
outpatient cardiac rehab and a HF disease management (DM) clinic is unknown.
Methods: OPTIMIZE-HF is a national registry/performance improvement (PI) program for 
pts hospitalized with HF. PI tools, including order sets and dc checklists, were provided to 
participating hospitals. A clinical leader (champion) was recommended to lead hospital 
teams in the PI effort. Use of PI tools, instruction delivery, cardiac rehab and DM referral 
were prospectively collected.
Results: 33,152 pts from 257 hospitals were included in this analysis. Mean pt age was 
71.2 years with 49% women, 71.2% Caucasian, 46.3% ischemic etiology, and mean 
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LVEF of 38.5%. Completion of all 6 JCAHO dc instructions was fulﬁlled in 17,786 (53.6%) 
and was strongly associated with referral to cardiac rehab (P<.0001) and outpatient DM 
clinic (P<.0001), as was completion of individual component instructions (Table 1). PI 
tools were utilized in 48.2% of pts. Use of a PI tool was strongly associated with delivery 
of complete dc instructions, referral to HF DM clinic, and referral to cardiac rehab (all 
P<.0001).
Conclusions: Hospital teams that consistently deliver instructions to pts with HF pre-
discharge are more likely to refer pts to outpatient DM programs and cardiac rehab. PI 
tool use is associated with an increase in the ability to provide optimal dc planning and 
follow-up.
Table 1: Association of DC Instruction Delivery to DM Program
Referral to Disease 
Management Clinic
Yes (n = 5,208)
Referral To Disease 
Management Clinic
No (n = 27,944)
Total 
Population
(N = 33,152)
P Value
Complete Discharge 
Instructions (All 6 
Components) (%)
78.3 49.1 53.6 <.0001
Discharge-1 Address 
Activity Level (%) 94.7 87.9 89.0 <.0001
Discharge-2 Address 
Diet (%) 96.6 91.3 92.1 <.0001
Discharge-3 Address 
Follow-Up (%) 98.7 96.3 96.7 <.0001
Discharge-4 Address 
Medications (%) 98.2 95.2 95.7 <.0001
Discharge-5 Address 
Worsening Symptoms
(%)
89.5 69.8 72.9 <.0001
Discharge-6 Address 
Weight Monitoring (%) 81.8 53.4 57.9 <.0001
Use of PI Tool (%) 65.1 45.1 48.2 <.0001
11:24 a.m.
847-5 Impact of Novel Critical Care Pathway for Management 
of Acute Coronary Syndrome Leads to Markedly 
Improved Compliance With Guidelines and Decreased 
Angina Symptoms at 12-Month Follow-Up
Emad F. Aziz, Sripal Bangalore, Dan Musat, Joseph Mathew, Stacy Vargel, Clenton 
Coleman, Lance Weathers, Olivier Frankenberger, Eyal Herzog, St. Luke’s-Roosevelt 
Hospital Center, New York City, NY
Background: Implementation of critical pathways and management plans for hospitalized 
patients is becoming a main stream in providing the sequence and timing of actions 
necessary to achieve the goal of quality care delivered with optimal efﬁciency. The 
effectiveness of such an approach has yet to be determined. The objective of this study is 
to investigate the impact of our “Advanced Cardiac Admission Program” (A.C.A.P.) on the 
process of patient care, treatment rates and clinical outcomes.
Methods: This is a pilot study that is conducted at St. Luke’s-Roosevelt Hospital Center. 
We compared the admission and discharge management plans for patients admitted 
with Acute Coronary Syndrome (ACS) and assessed the compliance with the AHA/ACC 
guidelines before and after the implementation of the ACAP Program.
Results: 215 patients of the Pre-ACAP group (mean age 54.6±15.8, 55% males), were 
compared to 269 patients of the Post-ACAP group (Mean age 59.9±15.9, 56% males), 
and were followed for 12 month. In the Post-ACAP patient group antiplatelet utilization 
rate on discharge improved from 34% to 91.4% (p<0.0001), beta-blocker use improved 
from 30% to 61.3% (p<0.0001), ACEi/ARB utilization improved from 31.7% to 67.6% 
(p<0.0001) and statin use rose from35.3% to 62.4% (p<0.0001). Advice on smoking 
cessation upon discharge improved from 15.3% to 86.6% (p<0.0001). Compared to the 
Pre-ACAP group at12-month follow up, the Post-ACAP patient group showed evidence of 
improvement in clinical outcomes as assessed by a decrease in the recurrence of angina 
symptoms hazard ratio 0.47 (95% CI=0.19-0.99, p=0.04). 
Conclusions: This study shows the impact of implementing a novel evidence-based 
cardiac critical pathway for ACS that leads to markedly improved compliance with 
published guidelines and decreased angina symptoms at 12-month follow-up.
11:36 a.m.
847-6 Clinical Pathway as a Strategy of Improving Care to 
Patients With an Acute Myocardial Infarction. From a 
Randomised Trial to Clinical Practice
Victor A. Umans, Carla J. Broers, Alfred E. Arnold, Jan H. Cornel, Medical Center 
Alkmaar, Alkmaar, The Netherlands
Background. Clinical pathways attempt to increase efﬁciency by organizing the care 
delivery process into analysable steps. However, full advantage of clinical pathways 
may only be reached if the process is governed by a ‘process care taker’. We introduced 
a multidisciplinary clinical pathway for acute MI pts with a nurse practitioner as case 
manager. The results were evaluated using a randomised study followed by a prospective 
registry.
Methods. In total, 543 consecutive AMI pts with/without ST elevation were evaluated. 
Initially, 200 pts were randomised to receive treatment involving a nurse practitioner 
(n=97) or residents (n=103). Both groups were supervised by the attending cardiologist.
Results of the randomised trial are in the table: 
% NP Resident P
Male 79 71 ns
STEMI 79 75 ns
PCI for STEMI 95 95 ns
Death 0 0 ns
Re-MI 0 4 ns
Re-PCI 1 1 ns
Admission time(days) 8.1 9.2 ns
Patient satisfaction with the new pathway was higher compared with regular care (7.6 
vs 6.4;p<0.01).
After completion of the randomised trial, all consecutive AMI pts were treated in the NP 
led clinical pathway (n=343). With ongoing experience, the length of stay reduced further 
from10.7 to 5.3 days (p<0.05) without clinical complications. All pts were alive at 30 days 
and none had a re-infarction.
Conclusion. A nurse-led clinical pathway for AMI pts is safely and efﬁcaciously introduced 
in a teaching hospital. The pathway reduced the length of stay with 45% and increased 
patient satisfaction. These results emphasize the importance of a case manager who is 
involved in the daily clinical care.
11:48 p.m.
847-7 Mayo Clinic Fast Track Protocol for ST-Elevation 
Myocardial Infarction: Process Improvements to 
Minimize Treatment Delays
Henry H. Ting, Malcolm R. Bell, John F. Bresnahan, Luis H. Haro, Meghan B. Lamp, 
Lavon N. Hammes, Choon-Chern Lim, Eric H. Yang, Charanjit S. Rihal, Mayo Clinic, 
Rochester, MN
Background: Patients with ST-elevation myocardial infarction (STEMI) presenting to 
regional community hospitals experience signiﬁcant treatment delays.
Methods: We report the Mayo Clinic Fast Track protocol for STEMI which implemented a 
standard treatment protocol based on current Guidelines and utilized Lean and Six Sigma 
methodology to improve clinical care processes. From December 2004 to September 
2005, 16 regional hospitals participated within 120 nautical miles from Mayo Clinic. For 
STEMI with onset of symptoms <3hours, thrombolysis and transfer is preferred. For 
STEMI with onset of symptoms >3hours, transfer for primary PCI is preferred. Innovations 
in clinical care processes include:
1. Prioritizing ECG acquisition at the regional hospital
2. Single phone call to activate the protocol and transport
3. Regional Emergency Department physician activates the  
Catheterization Lab
4. Standard guideline for selecting reperfusion strategy and adjunctive 
medications
5. Helicopter engine left running to minimize ground time
6. Glycoprotein IIB-IIIa inhibitor administered en route by transport team
7. Prospective web-based data collection tool
Results: 70 patients have been enrolled in the Fast Track with 31 (44%) treated with 
thrombolysis and 39 (56%) transferred for Primary PCI. (see Table)Conclusions:
The Mayo Clinic Fast Track has improved time to treatment for STEMI. We will continue 
to prospectively measure and report process and outcome metrics for quality of care.
Fast Track 
Thrombolytic 
(n=31)
Controls 
Thrombolytic(n=4)
Fast Track 
PCI (n=39)
Controls 
Primary PCI 
(n=9)
Regional door-
to-Thrombolysis 
(median, minutes)
23 56
Regional door-
to-Balloon 
(median, 
minutes)
109 194
Door-to-ECG 5 10 Door 1-to-ECG 5 16
ECG-to-
Thrombolysis 18 46
ECG-to-
Activation 15 46
Activation-to-
Door2 54 71
Door2-to-Balloon 35 61
Noon
847-8 Comparison of Reperfusion Times in Patients 
Transferred for Primary Angioplasty for ST Elevation 
Myocardial Infarction Prior to and After Instituting a 
Regional Myocardial Infarction Alert Protocol
Michael A. Rossi, Joel R. Garcia, J. Patrick Kleaveland, Bruce A. Feldman, Michael J. 
Durkin, Richard MacKenzie, Frank Penatar, Thomas Wasser, Lehigh Valley Hospital and 
Health Network, Allentown, PA, The Pennsylvania State University/Milton S. Hershey 
Medical Center, Hershey, PA
Background: The beneﬁts of prompt primary percutaneous intervention (PCI) over 
thrombolysis as a reperfusion strategy for patients with acute ST-elevation myocardial 
(STEMI) have been well established. However, the ability to achieve rapid transfer of 
these patients presenting to hospitals without PCI capabilities has not been well studied. 
Our objective was to compare reperfusion times (ED door to balloon) for patients with 
STEMI presenting to a hospital without PCI capabilities before and after institution of a 
“Regional MI Alert” protocol.
Methods: We performed a retrospective chart review of consecutive patients with STEMI 
diagnosed on arrival to the ED at a community hospital, who were then transferred to a 
tertiary care hospital with PCI capabilities, 30 miles away. A “Regional MI Alert” protocol 
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was jointly developed between the two hospitals to expedite transfer of STEMI patients for 
emergency PCI. This protocol included coordinated communications for air or ambulance 
transport, physician and cath lab notiﬁcation, and treatment algorithms for aspirin, 
heparin, beta blockers, and glycoprotein IIb/IIIa inhibitors. We evaluated all patients in 
the year prior to and following protocol initiation. Mean and median times to reperfusion 
(minutes) were compared using the group T-test and Mann-Whitney U test.
Results: Comparison of 18 patients in calendar year 2003 admitted with STEMI 
and transferred for PCI (pre-protocol) with 23 patients in the year following protocol 
implementation (2004-2005) demonstrated signiﬁcant improvements in median door to 
balloon times, from 164 to 110 (33% reduction, p<0.001) and mean times, from 292 +/- 
297 to 114 +/-24, (61% reduction, p=0.04). There was one death in the pre-protocol and 
none in the post-protocol group (p=ns).
Conclusions: In patients who present with STEMI to hospitals without PCI capabilities, 
primary PCI may still be the preferred reperfusion strategy, if performed in a timely fashion. 
Our study shows that implementation of an organized, team based approach with a 
“Regional MI Alert” protocol to expedite transfer of STEMI patients for primary PCI can 
successfully be performed and achieve signiﬁcant improvements in door to balloon times.
POSTER SESSION
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1036-145 Clinical and Business Integration in a Pediatric/
Congenital Heart Center
Philip C. Smith, Meredith R. Slosberg, Akron Children’s Hospital, Akron, OH
Background: In 2001, a de novo, medical and surgical pediatric/congenital cardiovascular 
service was established at Akron Children’s Hospital. A novel infrastructure was designed 
to excel at managing the four emerging dimensions of healthcare industry success: 
access, quality, risk and cost.
Methods: The ﬁrst step in establishing the Enterprise was to deﬁne a co-directorship 
between a Clinical Director (Physician Leader) and Administrative Director (Business 
Leader), absent the traditional subordinate-superordinate report relationship. The 
second step was to reposition the Divisions of Cardiology and Cardiothoracic Surgery 
away from their traditional departmental alignments and to develop new organizational 
report structures and cost centers. The third step was to employ all physicians and staff 
within the Enterprise and establish direct report relationships to the Clinical Director and 
Administrative Directors, respectively to provide operational alignment and accountability. 
The ﬁnal step was to establish a culture of trust between physicians and administrators 
to foster interdependence in the delivery of service including business development and 
process improvement goals.
Results: After four years of operation the enterprise has grown to 10 physicians and 
70 staff members. The enterprise operates 3 clinical sites and has 8 community hospital 
partnerships in Northeast Ohio. The service performs over 8,000 clinic visits, 9,000 
echos, 300 cath/intervention/EP cases, and 145 surgical cases annually. We maintain 
non-urgent access times of less than 3 weeks, achieve 97% patient and 99% referring 
physician satisfaction ratings and deliver 1% overall operative mortality in combination 
with solid operating margins.
Conclusions: An integrated organizational structure provides a compelling alternative 
to traditional academic departmental alignments for managing the variables of the new 
healthcare environment. It is replicable across the healthcare industry if physicians and 
administrators acknowledge the changes in the external environment and are willing to 
embrace the merits of a new organizational paradigm.
1036-146 The Veterans Affairs Computerized Patient Record 
System Provides an Identical Assessment of All Cause 
Mortality as Compared to Methods Used in Traditional 
Clinical Trials
Runa Bhattacharya, Michael D. Greenberg, Peter Kokkinos, Gregory Trachiotis, Ross 
Fletcher, Washington DC VA Medical Center, Washington, DC
Background: In clinical trials accurate tracking of mortality is a complex and labor 
intensive process involving extensive follow up visits, phone interviews, providers contact, 
and use of national registries. The Computerized Patient Records System(CPRS-VistA) 
is among the largest, integrated electronic medical records plateform utililzed at over 
160 Veterans Affairs Medical Centers. It contains a unique data ﬁeld which is populated 
once a patient dies. We hypothesized that CPRS-VistA could provide “all cause mortality” 
data equivelent to that found through the more elaborate and complex methods utilized 
in clinical trials.
Methods:Mortality data were obtained for a total of 324 Veterans enrolled in 9 multicenter 
clinical trails. Trials from a variety of disiplines (cardiology-2, infectious disease-4, oncology-
2; surgery-1) and sponsors (NIH-7; industry-1; VA Coop-1) were chosen. Patients status 
(i.e., alive or dead) was also determined by a blinded investigator looking soley at the 
CPRS-VistA medical record. Results: Of the 65 deaths in the study population the VA 
electronic medical record correctly identiﬁed all cause mortality in 97% of cases. Only 2 
of the 65 deaths (3%) in the clinical trials were not accurately detected by CPRS-VistA. 
Living patients were correctly identiﬁed 99.6% of the time.
Conclusions: The CPRS-VistA electronic medical record can be utilized to accurately 
assess all cause mortality and provides an important tool for clinical trials.
All Cause Mortality Assessment
Clinical Trials CPRS-VistA
Alive 259 260
Expired 65 64
 
1036-147 Day-case Procedures Are Safe in the Majority of 
Patients Undergoing Elective Percutaneous Coronary 
Intervention
Sandhir Prasad, Sujith Seneviratne, Mark Weatherall, Mark Simmonds, Phillip Matsis, 
Andrew Aitken, Russell Anscombe, Scott A. Harding, Wellington Hospital, Wellington, New 
Zealand, Wellington School of Medicine and Health Sciences, Wellington, New Zealand
Background: The move towards day-case percutaneous coronary intervention (PCI) 
represents a major change in practice. The safety and efﬁcacy of this approach has 
not been well established. We aimed to assess the safety and feasibility of same-day 
discharge in an unselected cohort of patients undergoing elective PCI.
Methods: All patients undergoing elective PCI at a single tertiary referral center between 
January 2001 and August 2005 were considered for same-day discharge. There were no 
exclusions. Decisions regarding same-day discharge were made at the post-procedural 
review by the cardiologist. Demographics, procedural variables and outcomes were 
obtained from review of the cardiac catheterization laboratory database, medical records 
and clinic review.
Results: The total number of patients was 1005. The mean age of the patients was 
63.2 ± 10.2 years. Vascular access was via the femoral approach in 90.8%. A total of 
1382 lesions were treated, with 24% of patients undergoing multivessel intervention. 
Angiographic success was achieved in 96.1% of lesions. In-hospital there was 1 death 
(0.1%), 20 (2.0%) myocardial infarctions and 9 (0.9%) urgent revascularizations. Same-
day discharge was achieved in 862 (85.8%) patients. The primary reasons for failure 
of same-day discharge were myocardial infarction (2.0%), hematoma or other groin 
complications (3.1%), chest pain (2.0%), complex procedure (1.3%), Abciximab use 
(1.4%), late sheath removal (1.6%), social reasons (0.8%), and miscellaneous (2.1%). 
By multivariate analysis hypertension (OR 1.9, 95% CI 1.8 to 2.8), femoral access (3.1; 
1.2 to 7.9), lesion complexity (2.2; 1.5 to 3.3), increasing sheath size (5.0; 1.4 to 18.2), 
and decreasing body mass index (1.05; 1 to 1.1) were independent predictors of failure 
of same-day discharge. Of those discharged on the same day only 5 (0.5%) patients 
experienced any complications during the ﬁrst 24 hours following discharge (1 stent 
thrombosis, 2 hematomas, 2 vascular complications).
Conclusion: We have demonstrated the safety and feasibility of same-day discharge in a 
large cohort of unselected patients undergoing elective PCI.
1036-148 Improved Risk Stratiﬁcation in Primary Prevention 
by Utilizing the Impact of Life Style Factors for the 
Calculation of Cardiovascular Risk in Three Different 
Scoring Systems
Helmut K. Gohlke, Moritz Winter, Klaus Held, Marthin Karoff, Herz-Zentrum, Bad 
Krozingen, Germany, Klinik Königsfeld der LVA Westfalen, Ennepetal, Germany
Background:Risk stratiﬁcation (RS) is important for the decision on drug treatment in 
primary prevention (PP) of cardiovascular (CV) events. Life style factors contribute almost 
50% to the population attributable fraction of CV events. Despite a good data basis from 
the literature life style related factors like body mass index (BMI), physical activity (PA) 
and quantitative cigarette consumption(Cig/day) are not or not quantitatively represented 
in the Framingham-Risk Score,the PROCAM or the new ESC-SCORE-system. The 
additional use of these factors could improve RS in PP.
Methods: A new software program for cardiovascular risk management (CARRISMA) 
was developed to improve RS by calculating and applying the prognostic impact of BMI, 
PA and Cig/day adjusted to age and gender on top of one of the existing scores ( modif. 
Framingham,ESC-SCORE and PROCAM) based on multivariate regression analyses in 
peer review journals.
Results: A 10 year Framingham risk of 16% is increased to 37% by considering smoking 
of 30 cig/day instead of just “smoking” and by taking into account a BMI of 31. The 10 
year ESC-SCORE CV mortality risk increases accordingly from 3% to 7% by considering 
these additional factors.
On the other hand a 10 year Framingham risk of a 55 y/o non smoker with a cholesterol 
of 285mg/dl,HDL 45mg/dl,TG 200mg/dl, BP syst of 155mmHg decreases from 20% to 
14%, by considering a BMI of 21 and a PA volume of 2500 Kcal/week. With the ESC-
SCORE the 10 year mortality in a high risk region accordingly decreases from 5% to 3%. 
CARRISMA also allows comparison of the results obtained with the three different scoring 
systems. In addition the modiﬁcation of individual or several risk factors by inﬂuencing 
Cig/day,PA,and body weight by life style modiﬁcation or lowering (LDL)-cholesterol and/or 
blood pressure by use of medications can be estimated and demonstrated to the patient.
Conclusions: CARRISMA facilitates RS by application of currently available knowledge 
from the epidemiological and preventive literature in the individual patient in a user friendly 
manner . It allows comparison of different scoring systems and enhances interaction with 
the patient to improve compliance.
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1036-149 Calculating LDL and Blood Pressure Goals Per ATP III 
and JNC VII Just Prior to an Ofﬁce Visit Helps Close the 
Gap Between Guidelines and Practice
Lisa C. Pastel, Allison Cardello, Noel Curcio, Sarah M. Scott, Salvatore P. Costa, 
Dartmouth Hitchcock Medical Center, Lebanon, NH
Background: Prior studies have demonstrated that when medical charts are reviewed 
for adherence to cholesterol and BP guidelines, even cardiovascular specialists leave 
a gap between guidelines and clinical practice. As pay for performance models are 
increasingly setting standards for medical chart audits, we hypothesized that by including 
the calculation of LDL and BP goals into the vitals signs process, clinicians would be more 
likely to take action to address suboptimal risk factors.
Methods: This is a prospective cohort study with historical controls. The study group 
(A) consisted of 100 consecutive cardiology outpatients at an academic center (Spring 
2005). During acquisition of the vital signs, LDL and BP goals per ATP III and JNC VII 
were calculated and a summary datasheet highlighting suboptimal targets was placed 
on the medical chart prior to the visit. Clinicians could review the datasheet but were not 
aware of study end-points. A control group (B) consisted of 100 consecutive cardiology 
outpatients from 6 months prior when no datasheet was provided. Ofﬁce notes were read 
by two blinded reviewers and conclusions were made as to whether there was an “action 
taken” to address suboptimal goals. “Action taken” was deﬁned as: updating lipid proﬁles, 
recommending therapeutic lifestyle changes, starting a new medication, or increasing a 
medication. Fisher’s exact test was used to test for statistical signiﬁcance.
Results: At baseline the number of patients at or below their goal LDL between the two 
groups was not signiﬁcant (p=0.4). However, among those patients not at a conﬁrmed 
goal LDL, we observed a signiﬁcant difference in action taken when the datasheet was 
provided: 60% of patients in group A vs 32% in group B (p=0.002). At baseline the number 
of patients at or below their goal BP between the two groups was not signiﬁcant (p=0.5). 
However, among those not at goal BP, we observed a signiﬁcant difference in action taken 
with the datasheet: 57% in group A vs 33% in group B (p=0.03).
Conclusions: Calculating goal LDL and BP goals so that this information can be used 
during an ofﬁce visit appears to be an effective way of encouraging busy clinicians to 
address suboptimal cardiovascular risk factors.
1036-150 Taking the Doctor Out of the Loop: The Impact of 
a Technician Led Follow-Up Clinic for Heart Valve 
Disease
Wasing Taggu, Ann Topham, Lesley Hart, John Silberbauer, A. Neil Sulke, Nikhil R. 
Patel, Guy Lloyd, Eastbourne District General Hospital, Eastbourne, United Kingdom
Background: Despite clear guidelines, follow up of Heart valve disease (HVD) is often 
poorly standardized and devolved to junior clinicians. We therefore established a service 
whereby patients requiring follow up only for their valve condition were assessed by senior 
echocardiography technicians working under protocol. Clinical support was provided only 
when required as judged by the technician.
Methods: Patient care was compared for the two years before and after the initiation of 
the valve clinic.
Results: 382 patients were enrolled (197 (%) male, mean age 51 (range 17-94) years). 
The valve diagnoses (non exclusive) were; mitral stenosis 15, mitral regurgitation 121, 
aortic stenosis 92, aortic regurgitation 169, mechanical prosthesis 103, bioprosthesis 44, 
previous MV repair 14 and valvuloplasty 2. Following valve clinic attendance, the median 
yearly echocardiogram rate was reduced from 2 (range 1-10) to 1 (range 1-5) (P<0.01) 
807 echo visits were performed before the clinic compared with 550 after the clinic. The 
total number of outpatient visits dropped from 998 to 31 after the clinic. The median 
number of outpatient visit dropped from 3 (range 1-6) to 0 (0-3) (P<0.01). The number of 
patients following AHA guidelines rose from 157 (41%) to 354 (92%) (p<0.01). 12 (3%) 
patients were referred back to outpatients due to change in clinical condition or requiring 
surgical intervention. Documented evidence of endocarditis prophylaxis advice given rose 
to 373(97%) from 338 (88%) after the clinic.
Conclusion: Protocol based, technician led, follow up clinics for HVD patients signiﬁcantly 
improved the quality of care and decreased the burden on the cardiology clinic and 
reduced the total number of echocardiograms performed, without compromising safety. 
This may be highly cost effective way of improving patient care.
1036-151 Early Results of a Nurse-Based Outpatient Telemedicine 
Project for Patients After Acute Coronary Syndrome
Carsten M. Schmalfuss, Michelle Ruby, Vlady Ortiz, Eric Marshall, Sherry Kline, Richard 
Schoﬁeld, Malcom Randall VA Medical Center, Gainesville, FL
BACKGROUND: Patients hospitalized with acute coronary syndrome (ACS) are at high 
risk for recurrent events during the ﬁrst months after discharge. Evidence based guidelines 
for post-discharge treatment to reduce this risk are available but not consistently applied. 
Educational programs like “Get with the Guidelines” by the AHA have shown improvement 
in guideline-directed treatment at discharge however patient compliance still drops 
signiﬁcantly in the following months.
METHOD: We have designed a nurse-based post-ACS discharge telemedicine program 
to increase medication compliance and reduce risk factors for coronary artery disease. 
Enrolled patients use a one-way phone-based telecommunication device for daily 
reporting of vital signs, medicine compliance and to get education on risk factors. 
Transmitted results are reviewed daily via a web server by the nurse. Signiﬁcant outliers 
are red-ﬂagged and acted upon immediately in conjunction with a cardiologist and a 
multidisciplinary team as needed.
RESULTS: We have enrolled 54 patients post-ACS (mean age 65 years, 1 female) all 
with follow-up of 6 months. Heart rate decreased from 75 to 67 bpm (P<0.001), systolic 
blood pressure decreased from 128 to 119 mmHg (p<0.05), cholesterol and LDL 
cholesterol decreased from 164 to 149mg/dl (p<0.05) and from 90 to 73 mg/dl (p<0.05) 
respectively. Use of aspirin, clopidogrel, betablocker and statin was 68%, 81%, 96% and 
90% at baseline and 97%, 91%, 98% and 94% at 6 months. Mean dose of metoprolol and 
simvastatin increased from 93 to 123 mg/d (p<0.05) and 44 to 47mg/d (NS) respectively 
at 6 months.CONCLUSION: Participation in our nurse-based telemedicine program for 
patients after acute coronary syndrome improved vital signs, reduced serum lipid levels, 
improved medication compliance, and increased daily dose of cardiac medications in 
predominantly male patients post-ACS. These important early outcomes would be 
expected to reduce the frequency of future cardiovascular events in this high-risk patient 
group. 
1036-152 Home Uptitration of Beta-blockers by Heart Failure 
Clinic Patients With Telephone Advice: A British 
experience
Sasalu M. Deepak, Carolyn A. Waywell, Waqas M. Khan, Teresa Coppinger, Alexander 
Borg, Louise B. Harper, Simon G. Williams, Nicholas H. Brooks, South Manchester 
University Hospitals - NHS Trust, Regional cardiac centre and Heart Transplant Unit, 
Manchester, United Kingdom
Background: Heart Failure Clinics (HFC) have helped to deliver the beneﬁts of optimal 
beta-blocker (BB) treatment in Britain. Due to practical difﬁculties and patient volume it 
is not always possible for a doctor to see these patients at frequent intervals to uptitrate 
BB. This delays the treatment optimization time and patient turnover. We attempted to 
overcome this by replacing some physician consults with specialist nurse-led telephone 
consultations.
Methods: Suitable patients were familiarized with the drug and subsequent doses during 
ﬁrst contact, and prescriptions for step up doses issued in advance. Patients phoned 
the HFC before each uptitration and were advised appropriately by our nurse. Bisoprolol 
(B) and Carvedilol (C) uptitration regimens were used at 2 weekly intervals, with a HFC 
visit midway. This meant 3 visits and 4 phone calls for B and 3 visits and 2 calls for C. 29 
patients were initiated on B, 1 changed over from B to C and 1 initiated on C.
Results: 30 patients, mean age 69yrs. Mean visits were 2.5. Median New York Heart 
Association class pre and post uptitration was 2 & 1; mean heart rate 83/min (± 1SD14) 
& 64/min (± 9) respectively. 20 were in sinus rhythm, 10 in atrial ﬁbrillation with 4 paced 
rhythms. Average time spent by the heart failure specialist nurse per phone call was under 
3 minutes (range 1-10). Doses achieved with B were, 10mg -17, 7.5mg - 1, 3.75mg - 1, 
2.5mg - 4, 1.25mg - 2 and C was 3.125mg in 1 patient. Nil in 4 patients. Mean B dose 
achieved was 7.6mg. 20 were successfully discharged by the end of home uptitration 
regime. 2 withdrew after the ﬁrst phone call due to inability to self-uptitrate. Any minor 
concerns regarding adverse effects or prescriptions etc were appropriately addressed by 
the nurse over phone. They were also advised to see their family physician or come to the 
HFC early if needed. Overall HFC visits were reduced and BB satisfactorily uptitrated with 
out any adverse events as a result of telephonic uptitration. On an average, the patients 
who achieved target dose of B were discharged in 89 days. 
Conclusions: BB can be safely and effectively self-uptitrated by patients at home with 
telephone advice. This reduced our HFC physician consults and BB dose optimization time.
1036-153 Patient Satisfaction With a Home Based Program 
Designed to Treat Elderly Heart Failure Patients
Derek Sun, Ellen McAlinden, James Welsh, Allen J. Solomon, George Washington 
University, Washington, DC
Background: A program consisting of a care manager and a home monitor that measures 
pulse, blood pressure, weight, and oxygen saturation may improve morbidity and mortality 
in elderly heart failure patients. In addition, this service may be cost effective by reducing 
physician visits, emergency department visits and hospitalizations. However, these 
services can only be effective if patients are interested in participating in the program and 
feel that they are beneﬁted by it.
Methods: Medicare patients with congestive heart failure were enrolled in a Medicare 
Coordinated Care Demonstration Project entitled Mind My Heart. This program combines 
telephone calls and home visits by a care manager, with daily home minitoring of vital 
signs. After participating in the study for one year, 107 participants were asked to complete 
a survey to evaluate their understanding of heart failure, their medications, their ability to 
use their home monitoring equipment, as well as patient satisfaction with the program. 
The survey consisted of 21 questions, which patients scored between one and ﬁve.
Results: Patients in this survey demonstrated a high level of satisfaction with the program. 
Speciﬁcally, they had a better understanding of what heart failure is and how to treat it. 
They also felt that they had a great understanding of their medications, their diet, and how 
to operate the home monitoring system. Patients felt more comfortable living at home with 
heart failure and would encourage other people to take part in a program like this. Over 
90% of patients had a favorable response to all 21 questions, with a mean score of 4.6.
Conclusions: A population of elderly heart failure patients had a high level of satisfaction 
with a program consisting of care managers and a home monitoring system. Their 
improved understanding of heart failure and their medications, as well as their conﬁdence 
in the program, may lead to a decrease in heart failure related hospitalizations, morbidity 
and mortality.
1036-154 Enhanced Self-Efﬁcacy but not Knowledge Predicts 
Increased Physical Activity
Linda Zamora, Carol Homko, Suni Peterson, Gail Shirk, William P. Santamore, Robert 
C. Cross, Abul Kashem, Timothy McConnell, Alfred A. Bove, Temple University, 
Philadelphia, PA
Background: Regular physical activity reduces the risk for developing heart disease, 
hypertension, type 2 diabetes, as well as helping to control weight. As part of a larger 
Internet-based Telemedicine study, we examined the impact of baseline physical 
and psychosocial variables on activity levels among a cohort of inner city and rural 
underserved patients.
Methods: Subjects were enrolled in one-year internet-based telemedicine randomized 
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controlled trial to reduce cardiovascular disease (CVD) risk. All individuals were given 
pedometers and received education and counseling regarding CVD risk reduction and 
the importance of increased physical activity. At baseline, CVD knowledge (percent 
correct answers), risk perception (7 point Likert scale with zero representing average 
risk.) and exercise self-efﬁcacy (5 point Likert scale) were assessed.
Results: By 8-months, participants (N=85, age = 64.0 ± 8.1 years; BMI = 31.0 ± 3 6.1 
kg/m2; 40% female/ 60% male; 28% African American) were averaging 5041.1 steps/day 
(±3328.2) and had reduced their CVD risk by 1.1% (± 0.7%). Average CVD knowledge 
scores were 63.9% ± 13.9 % and mean levels of risk perception and exercise self-efﬁcacy 
were 0.20 ±1.4 and 2.7 ± 0.8 respectively. Utilizing multiple logistic regression, exercise 
self-efﬁcacy and assignment to the intervention group were found to be signiﬁcantly (p 
<0.01) associated with increased steps/day. This effect was independent of gender, age, 
CVD knowledge, perceived cardiovascular risk, or locality of residence.
Conclusions: These data support the concept that self-efﬁcacy inﬂuences the effort 
patients invest in a given task and the levels of performance attained. The promotion of 
exercise self-efﬁcacy is critical in the process of changing life-style behaviors to enhance 
cardiovascular health.
1036-155 Prevalence and Predictors of Advance Directives in 
Patients in the Cardiac Care Unit
James N. Kirkpatrick, Carole J. Guger, Savitri E. Fedson, University of Chicago, 
Chicago, IL
Background:
Despite effective therapies, mortality for patients with cardiovascular disease remains 
high and is difﬁcult to predict. Recent national guidelines recommend the discussion 
of advance directives (AD) with heart failure patients and the federal Patient Self 
Determination Act mandates such discussions with all hospitalized patients. However, 
there is scant information in the medical literature on the rate of AD, including living will 
(LW) and durable power of attorney for healthcare (DPA), among patients with serious 
heart disease. This study sought to discover the prevalence and predictors of AD among 
patients in the cardiac care unit (CCU).
Methods: 61 consecutive adult patients admitted to a single CCU were surveyed by a 
nurse or a physician regarding the presence of AD and whether they had been asked 
about AD in prior hospitalizations. Demographic data, type of outpatient physicians and 
medical history were collected.
Results: The average age of patients was 61 years (range: 19 - 92 years) and 50% were 
female. Forty patients (66%) had a past history of one or more potentially life-threatening 
cardiovascular diagnoses. Thirty percent reported AD (3 LW, 7 DPA, 8 both). Of the patients 
without LW or DPA, 38 (86%) wanted more information on AD. Twenty-four patients (39%) 
had no recollection of previously being asked about AD despite the fact that 13 had 
documented prior admissions and 8 had been admitted multiple times. By chi-square 
analysis, Caucasian race was associated with LW, and number of prior admissions was 
associated with DPA. There was a non-signiﬁcant trend toward an association between 
DPA and number of cardiac diagnoses. Conclusions: The majority of patients in this 
study had no AD, despite most having life-threatening illnesses. A signiﬁcant percentage 
reported that AD had never been addressed with them in prior hospitalizations. This 
study highlights the limitations of the current practice of AD discussions and the need to 
address AD with patients who have serious cardiovascular disease.
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